FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gabriel Hortobagyi

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Julie E Lang; Funda Meric-Bernstam; Melissa P Mitchell; Roshni Rao; Welela Tereffe; Isabelle Bedrosian; Lei Feng; Gabriel N Hortobagyi; Kelly K Hunt; Henry M Kuerer; Gildy V Babiera
Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival.
Howard A Burris; Edmond Chouinard; Michael Gnant; Gabriel N Hortobagyi; Anna Komorowski; Fabienne Lebrun; Patrick Neven; Katarina Petrakova; Martine Piccart; Kathleen I Pritchard; Jean-Francois Ricci; Hope S Rugo; Tarek Sahmoud; Tetiana Taran; Robyn Young; Jose Baselga; Hounayda Bauly; J Thaddeus Beck; Lee Bennett; Shinzaburo Noguchi
Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.
Michael Gnant; Peyman Hadji; Lowell L Hart; Gabriel N Hortobagyi; Hiroji Iwata; David Lebwohl; Hirofumi Mukai; Shinzaburo Noguchi; Martine Piccart; Jose Baselga; Howard A Burris; Mario Campone; Janice Eakle; Mona El-Hashimy; Matthias Geberth; Shantha Rao; Hope S Rugo; Tarek Sahmoud; Tetiana Taran; Kathleen I Pritchard
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gabriel Hortobagyi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Julie E Lang; Funda Meric-Bernstam; Melissa P Mitchell; Roshni Rao; Welela Tereffe; Isabelle Bedrosian; Lei Feng; Gabriel N Hortobagyi; Kelly K Hunt; Henry M Kuerer; Gildy V Babiera
Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival.
Annals of surgical oncology 2013;20(6):1893-9.
2013: Howard A Burris; Edmond Chouinard; Michael Gnant; Gabriel N Hortobagyi; Anna Komorowski; Fabienne Lebrun; Patrick Neven; Katarina Petrakova; Martine Piccart; Kathleen I Pritchard; Jean-Francois Ricci; Hope S Rugo; Tarek Sahmoud; Tetiana Taran; Robyn Young; Jose Baselga; Hounayda Bauly; J Thaddeus Beck; Lee Bennett; Shinzaburo Noguchi
Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.
Cancer 2013;119(10):1908-15.
2013: Michael Gnant; Peyman Hadji; Lowell L Hart; Gabriel N Hortobagyi; Hiroji Iwata; David Lebwohl; Hirofumi Mukai; Shinzaburo Noguchi; Martine Piccart; Jose Baselga; Howard A Burris; Mario Campone; Janice Eakle; Mona El-Hashimy; Matthias Geberth; Shantha Rao; Hope S Rugo; Tarek Sahmoud; Tetiana Taran; Kathleen I Pritchard
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.
Journal of the National Cancer Institute 2013;105(9):654-63.
2013: Mariana Chavez-Macgregor; Christina A Clarke; Gabriel N Hortobagyi; Daphne Lichtensztajn; Sharon H Giordano
Male breast cancer according to tumor subtype and race : A population-based study.
Cancer 2013;119(9):1611-7.
2013: Ricardo H Alvarez; Gabriel N Hortobagyi
Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer.
Breast cancer (Tokyo, Japan) 2013;20(2):103-10.
2013: Antonio Giordano; David Hajage; Gabriel N Hortobagyi; Jean-Yves Pierga; James M Reuben; Joseph Bland; Massimo Cristofanilli; Brian L Egleston; Francois-Clement Bidard
Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(6):1596-602.
2013: Gary R Zirpoli; G Thomas Budd; Kathy S Albain; Patrick M Brennan; Gregory Ciupak; Warren Davis; Julie R Gralow; Dawn L Hershman; Timothy Hobday; Chi-Chen Hong; Gabriel N Hortobagyi; Claudine Isaacs; Susan E McCann; Halle C F Moore; Muhammad Salim; James Stewart; Joseph M Unger; Christine B Ambrosone
Supplement use during an intergroup clinical trial for breast cancer (S0221).
Breast cancer research and treatment 2013;137(3):903-13.
2013: Elizabeth A Mittendorf; Merrick I Ross; Susan L Tucker; Min Yi; Gildy V Babiera; Isabelle Bedrosian; Thomas A Buchholz; Ana M Gonzalez-Angulo; Karen Hoffman; Gabriel N Hortobagyi; Henry M Kuerer; Funda Meric-Bernstam; Kelly K Hunt
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
Annals of surgery 2013;257(2):173-9.
2013: Naoki Hayashi; Gabriel N Hortobagyi; John E Madewell; Naoki Niikura; Richard L Theriault; Colleen M Costelloe; Tsuyoshi Hamaoka; Caimiao Wei; Naoto T Ueno
A prospective study of bone tumor response assessment in metastatic breast cancer.
Clinical breast cancer 2013;13(1):24-30.
2013: Soley Bayraktar; Angelica M Gutierrez Barrera; Gabriel N Hortobagyi; Kelly Hunt; Jennifer Litton; Diane Liu; Lajos Pusztai; Fraser Symmans; Vicente Valero; Yun Wu; Banu Arun
USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer.
Cancer journal (Sudbury, Mass.) 2013;19(1):10-7.
2013: Windy Dean-Colomb; Daniel J Booser; Terrie G Gornet; Beverly C Handy; Kenneth R Hess; Gabriel N Hortobagyi; Nuhad Ibrahim; Stacy L Moulder; Lajos Pusztai; Vicente Valero; Elliana Young; Francisco J Esteva
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.
Breast cancer research and treatment 2013;137(2):631-6.
2013: Funda Meric-Bernstam; Kaylene Ready; Ana Maria Gonzalez-Angulo; Angelica M Gutierrez-Barrera; Gabriel N Hortobagyi; Jennifer Litton; Karen H Lu; Lauren Mellor-Crummey; Banu K Arun
Genotype in BRCA-associated breast cancers.
The breast journal 2013;19(1):87-91.
2013: Ashley M Holder; Gabriel N Hortobagyi; Gordon B Mills; Lajos Pusztai; Argun Akcakanat; Huiqin Chen; Kim-Anh Do; W Fraser Symmans; Ana M Gonzalez-Angulo; Funda Meric-Bernstam
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.
Breast cancer research and treatment 2013;137(1):319-27.
2013: Francisco J Esteva; Ana M Gonzalez-Angulo; Marjorie C Green; Gabriel N Hortobagyi; Kimberly B Koenig; Mong-Hong Lee; Stacy L Moulder; James L Murray; Joe Ensor; Sai-Ching Yeung
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.
Cancer chemotherapy and pharmacology 2013;71(1):63-72.
2013: Scott D Ramsey; Sean R. Tunis; David Veenstra; Laurence H Baker; William E Barlow; John Crowley; Patricia Deverka; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.
Contemporary clinical trials 2013;34(1):1-9.
2013: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Meghan S Karuturi; Funda Meric-Bernstam; Gordon B Mills; Patricia A Thompson; Spyrus Tsavachidis; Melissa L Bondy; Mariana Chavez-MacGregor; Huiqin Chen; Kim-Anh Do; George R Blumenschein
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
Cancer 2013;119(1):7-15.
2012: Hiroko Masuda; Chandra Bartholomeusz; Hiroyoshi Doihara; Gabriel N Hortobagyi; Dongwei Zhang; Naoto T Ueno
Role of epidermal growth factor receptor in breast cancer.
Breast cancer research and treatment 2012;136(2):331-45.
2012: Linda Vahdat; Louise Yelle; Henri H Roché; Joseph A Sparano; Eva S Thomas; Craig A Bunnell; Monica Fornier; Gabriel N Hortobagyi; Miguel Martín; Pralay Mukhopadhyay; Ronald A Peck; Edith A Perez
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(11):2661-8.
2012: Shaheenah Dawood; Gabriel N Hortobagyi; Xiudong Lei; Jennifer K Litton; Thomas A Buchholz; Ana M Gonzalez-Angulo
Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.
Clinical breast cancer 2012;12(5):364-72.
2012: Javier Cortés; Shaheenah Dawood; Leticia De Mattos-Arruda; Patricia Gómez; Antonio González-Martín; Antonio Llombart-Cussac; Ana Lluch; Edith A Perez; Hope S Rugo; Orlando Silva; Emiliano Calvo; Gabriel N Hortobagyi
Progress against solid tumors in danger: the metastatic breast cancer example.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(28):3444-7.
2012: Chun-Te Chen; Yi Du; Gabriel N Hortobagyi; Jung-Mao Hsu; Hsu-Ping Kuo; Hirohito Yamaguchi; Mien-Chie Hung
Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.
Molecular cancer therapeutics 2012;11(10):2212-21.
2012: Shaheenah Dawood; Gabriel N Hortobagyi; Xiudong Lei; Jennifer K Litton; Thomas A Buchholz; Ana M Gonzalez-Angulo
Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer.
Cancer 2012;118(19):4652-9.
2012: Yann Delpech; K R Hess; Gabriel N Hortobagyi; L Hsu; D Mauro; R Natowicz; M Ayers; Emmanuel Barranger; Charles Coutant; Roman Rouzier; Y Wu; Lajos Pusztai
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Breast cancer research and treatment 2012;135(2):619-27.
2012: Qingfei Wang; Yi Xiao; Samuel W Brady; Hailiang Ge; Gabriel N Hortobagyi; Elizabeth M Jaffee; Ping Li; Shau-Hsuan Li; William J Muller; Ozgur Sahin; Hai Wang; Dihua Yu
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer.
Cancer research 2012;72(17):4417-28.
2012: Phuong Khanh Morrow; Rashmi K Murthy; Hope S Rugo; Walter J Urba; David E Weng; Anthony D Elias; Joe D Ensor; Gilad S Gordon; Kim A Margolin; Gabriel N Hortobagyi
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Cancer 2012;118(17):4098-104.
2012: Rita S Mehta; Nagendra R Tirumali; Ted A Vandenberg; Danika L Lew; Robert B Livingston; Kathy S Albain; William E Barlow; Shaker R Dakhil; Julie R Gralow; Daniel F Hayes; Gabriel N Hortobagyi
Combination anastrozole and fulvestrant in metastatic breast cancer.
The New England journal of medicine 2012;367(5):435-44.
2012: Ricardo H Alvarez; Yun Gong; Gabriel N Hortobagyi; Naoto T Ueno; Pamela A Alizadeh; Vicente Valero
Metastasis in the breast mimicking inflammatory breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(22):e202-6.
2012: Ugo De Giorgi; Antonio Giordano; Mario Giuliano; Gabriel N Hortobagyi; Michal Mego; James M Reuben; Emanuela Scarpi; Naoto T Ueno; Vicente Valero; Massimo Cristofanilli
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.
Clinical breast cancer 2012;12(4):264-9.
2012: Libero Santarpia; Katherine Stemke-Hale; W Fraser Symmans; Vicente Valero; Tatiana Vidaurre; Bailiang Wang; Elliana J Young; Yuan Qi; Daniel J Booser; Giulia Bottai; Angelo Di Leo; Henry Gomez; Ana M Gonzalez-Angulo; Beth Hellerstedt; Frankie A Holmes; Gabriel N Hortobagyi; Joyce O'Shaughnessy; John Pippen; Lajos Pusztai
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.
Breast cancer research and treatment 2012;134(1):333-43.
2012: Sharon H Giordano; Gabriel N Hortobagyi; Yong Fang Kuo; Yu-Li Lin; James S Goodwin
Decline in the use of anthracyclines for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2232-9.
2012: Harold J Burstein; Gabriel N Hortobagyi; Kathy S Albain; Larry Norton; Edith A Perez; Martine J Piccart-Gebhart; Eric P Winer; Norman Wolmark; Clifford A Hudis
Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2179-82.
2012: Stacy Moulder; James L Murray; Edgardo Rivera; Daniel Booser; Abeena Brewster; Massimo Cristofanilli; Joe Ensor; Sharon H Giordano; Gregory Gladish; Ana Maria Gonzalez-Angulo; Gabriel N Hortobagyi; Julia Moore; Hai T Tran
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer.
Cancer 2012;118(9):2378-84.
2012: A Giordano; M Giuliano; Beverly C Handy; Gabriel N Hortobagyi; S Jackson; James M Reuben; Naoto T Ueno; Vicente Valero; R H Alvarez; Eleni Andreopoulou; Grazia Arpino; Michele De Laurentiis; Sabino De Placido; Massimo Cristofanilli
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(5):1144-50.
2012: Soley Bayraktar; Aman U Buzdar; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Henry M Kuerer; Xiudong Lei; Amal Melhem-Bertrandt; Aysegul A Sahin; Vicente Valero; Funda Meric-Bernstam
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.
Cancer 2012;118(9):2385-93.
2012: Kanwal P Raghav; Wenting Wang; George R Blumenschein; Mariana Chavez-MacGregor; Gabriel N Hortobagyi; Shuying Liu; Xiaolong Meng; Funda Meric-Bernstam; Gordon B Mills; Ana M Gonzalez-Angulo
cMET and phospho-cMET protein levels in breast cancers and survival outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2269-77.
2012: Naoki Niikura; Shana L Palla; Naoki Hayashi; Gabriel N Hortobagyi; Jun Liu; Yutaka Tokuda; Naoto T Ueno; Richard L Theriault
Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.
Cancer 2012;118(8):2039-47.
2012: Shaheenah Dawood; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Naoto T Ueno; Vicente Valero; Wendy A Woodward; Thomas Buchholz; Massimo Cristofanilli
Identifying factors that impact survival among women with inflammatory breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(4):870-5.
2012: Naoki Hayashi; Gabriel N Hortobagyi; Seigo Nakamura; Hidekazu Ota; Yuji Shimoda; Yasuharu Tokuda; Hiroshi Yagata; Atsushi Yoshida; Massimo Cristofanilli; Naoto T Ueno
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.
International journal of clinical oncology 2012;17(2):96-104.
2012: Catherine M Kelly; Eva S Thomas; Vicente Valero; Ronald S Walters; Daniel J Booser; Abenaa M Brewster; Kristine Broglio; Ana M Gonzalez-Angulo; Marjorie C Green; Gabriel N Hortobagyi; Kelly K Hunt; Nuhad K Ibrahim; Aman U Buzdar
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):930-5.
2012: Soley Bayraktar; Nisreen Elsayegh; Angelica M Gutierrez Barrera; Gabriel N Hortobagyi; Henry Kuerer; Heather Lin; Jennifer Litton; Funda Meric-Bernstam; Kimberly I Muse; Kaylene Ready; Tunc Tasbas; Constance T Albarracin; Banu Arun
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
Cancer 2012;118(6):1515-22.
2012: Kanwal P S Raghav; Aysegul Sahin; Thomas A Buchholz; Marianan Chavez-Macgregor; Kim-Anh Do; Leonel F Hernandez-Aya; Gabriel N Hortobagyi; Xiudong Lei; Funda Meric-Bernstam; Ana M Gonzalez-Angulo
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.
Cancer 2012;118(6):1498-506.
2012: B Dutta; Gabriel N Hortobagyi; V Lazar; Gordon B Mills; L Pusztai; Y Qi; C Y Shiang; W F Symmans; Naoto T Ueno; B Wang; R Agarwal; F André; G Bianchini; Gábor Balázsi
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
British journal of cancer 2012;106(6):1107-16.
2012: Takayuki Iwamoto; Kimberly Koenig; Junji Matsuoka; James L Murray; Daniel J Booser; Francisco J Esteva; Christos Hatzis; Gabriel N Hortobagyi; Yuan Qi; Weiwei Shi; W Fraser Symmans; Naoto T Ueno; Vicente Valero; Elliana J Yang; Jie Zhang; Lajos Pusztai
Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):729-34.
2012: Chia-Wei Li; Seung-Oe Lim; Been-Ren Lin; Yan Wang; Ting-Jung Wu; Yun Wu; Weiya Xia; Hirohito Yamaguchi; Muh-Hwa Yang; Neng-Kai Yang; Chi-Hong Chao; Qingqing Ding; Gabriel N Hortobagyi; Jennifer L Hsu; Longfei Huo; Adam M LaBaff; Yun-Ju Lai; Mien-Chie Hung
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.
Cancer research 2012;72(5):1290-300.
2012: Soley Bayraktar; Leonel F Hernadez-Aya; Gabriel N Hortobagyi; Limin Hsu; Xiudong Lei; Jennifer K Litton; Funda Meric-Bernstam; Ana M Gonzalez-Angulo
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
Cancer 2012;118(5):1202-11.
2012: Naoki Niikura; Shana L Palla; Yutaka Tokuda; Yun Gong; Ana M Gonzalez-Angulo; Naoki Hayashi; Gabriel N Hortobagyi; Jun Liu; Elizabeth A Mittendorf; Naoto T Ueno
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(6):593-9.
2012: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Takayuki Iwamoto; Shuying Liu; Funda Meric-Bernstam; Gordon B Mills; Huiqin Chen; Kim-Anh Do; W Fraser Symmans; Lajos Pusztai
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(4):1109-19.
2012: Amal Melhem-Bertrandt; Elias Obeid; Olufunmilayo I Olopade; Kaylene J Ready; Louise C Strong; Jasmina Bojadzieva; Angelica M Gutierrez-Barrera; Gabriel N Hortobagyi; Jennifer K Litton; Diane D Liu; Banu K Arun
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Cancer 2012;118(4):908-13.
2012: José Baselga; J Thaddeus Beck; Howard A Burris; Mario Campone; Ines Deleu; Michael Gnant; Thomas Bachelot; Yoshinori Ito; Fabienne Lebrun; David Lebwohl; Pabak Mukhopadhyay; Shinzaburo Noguchi; Alejandra Perez; Martine Piccart; Kathleen I Pritchard; Hope S Rugo; Tarek Sahmoud; Luc Vittori; Zhiying Xu; Denise Yardley; Gabriel N Hortobagyi
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
The New England journal of medicine 2012;366(6):520-9.
2012: Jennifer Keating Litton; Banu K Arun; Powel H Brown; Gabriel N Hortobagyi
Aromatase inhibitors and breast cancer prevention.
Expert opinion on pharmacotherapy 2012;13(3):325-31.
2012: Banu Arun; Abenaa Brewster; Aman U Buzdar; Francisco J Esteva; Marjorie Green; Angelica Gutierrez-Barrera; Gabriel N Hortobagyi; Diane Liu; Edgardo Rivera; Ugur Akar; Vicente Valero; Nour Sneige
Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
Cancer prevention research (Philadelphia, Pa.) 2012;5(2):276-82.
2012: Naoki Hayashi; Gabriel N Hortobagyi; Seigo Nakamura; Hidekazu Ota; Yasuharu Tokuda; Hiroshi Yagata; Atsushi Yoshida; Massimo Cristofanilli; Naoto T Ueno
Serum HER2 levels determined by two methods in patients with metastatic breast cancer.
International journal of clinical oncology 2012;17(1):55-62.
2012: Michal Mego; Yago Nieto; Sanda Tin; Naoto T Ueno; Qiong Wu; Richard E Champlin; Evan N Cohen; Massimo Cristofanilli; Hui Gao; Antonio Giordano; Gabriel N Hortobagyi; Bang-Ning Lee; Ping Liu; James M Reuben
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation.
Journal of Cancer 2012;3():369-80.
2012: Gabriel N Hortobagyi
Toward individualized breast cancer therapy: translating biological concepts to the bedside.
The oncologist 2012;17(4):577-84.
2012: Carlos H Barcenas; Thomas A Buchholz; Zhigang Duan; Gabriel N Hortobagyi; Ning Zhang; Hui Zhao; Sharon H Giordano
Anthracycline regimen adherence in older patients with early breast cancer.
The oncologist 2012;17(3):303-11.
2012: Anne F Schott; James L Wade; Keith S Lanier; Danika L Lew; Robert B Livingston; Kathy S Albain; William E Barlow; Helen K Chew; Julie R Gralow; Daniel F Hayes; Gabriel N Hortobagyi
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.
The oncologist 2012;17(2):179-87.
2011: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Is there an ideal way to combine trastuzumab with chemotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4474-6.
2011: Lara E Sucheston; G Thomas Budd; Song Yao; Hua Zhao; Gary Zirpoli; Kathy S Albain; William E Barlow; Gregory L Ciupak; Warren Davis; Julie R Gralow; Daniel F Hayes; Dawn L Hershman; Timothy J Hobday; Gabriel N Hortobagyi; Claudine Isaacs; Song Liu; Robert B Livingston; Halle C F Moore; Muhammad Salim; James A Stewart; Christine B Ambrosone
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).
Breast cancer research and treatment 2011;130(3):993-1002.
2011: Jen-Liang Su; Ying-Nai Wang; Hirohito Yamaguchi; How-Wen Ko; Dung-Fang Lee; Robert C Bast; Yi-Wen Chang; Poshen B Chen; Xiaoyun Cheng; Gabriel N Hortobagyi; Chao-Feng Hou; Michael Hsiao; Jung-Mao Hsu; Kuo-Tai Hua; Mien-Chie Hung
FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.
Cancer research 2011;71(21):6878-87.
2011: Takayuki Iwamoto; Sang Bae Kim; Ju Seog Lee; Junji Matsuoka; Giampaolo Bianchini; Gabriel N Hortobagyi; Rebekah E Hubbard; W Fraser Symmans; Elliana Young; Lajos Pusztai
First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations.
Breast cancer research and treatment 2011;130(1):155-64.
2011: Soley Bayraktar; Ana M Gonzalez-Angulo; Angelica M Gutierrez-Barrera; Gabriel N Hortobagyi; E Lin; Jennifer K Litton; Diane Liu; Funda Meric-Bernstam; Tunc Tasbas; Ugur Akar; Constance T Albarracin; Banu Arun
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
Breast cancer research and treatment 2011;130(1):145-53.
2011: Robert B Livingston; Melanie E Royce; Joseph J Kash; Danika L Lew; Kathy S Albain; William E Barlow; Lawrence E Flaherty; Julie R Gralow; Gabriel N Hortobagyi
SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.
Breast cancer research and treatment 2011;130(1):123-31.
2011: Banu Arun; Deann Atchley; Soley Bayraktar; Angelica M Gutierrez Barrera; Gabriel N Hortobagyi; Jennifer Keating Litton; Diane D Liu; Funda Meric-Bernstam; Lajos Pusztai; Vicente Valero; Constance T Albarracin
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(28):3739-46.
2011: Rachel L Theriault; Wendy A Woodward; Mariana Chavez-Macgregor; Huiqin Chen; Gabriel N Hortobagyi; Jennifer K Litton; Funda Meric-Bernstam; Elizabeth A Mittendorf; Phuong K Morrow; Aysegul Sahin; Ana M Gonzalez-Angulo
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype.
Clinical breast cancer 2011;11(5):325-31.
2011: Naoki Hayashi; Gabriel N Hortobagyi; Seigo Nakamura; Hidekazu Ota; Yuji Shimoda; Massimo Cristofanilli; Hiroshi Yagata; Naoto T Ueno
Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case series.
International journal of clinical oncology 2011;16(5):596-600.
2011: Jing-Yu Lang; Funda Meric-Bernstam; Qingfei Wang; Wendy A Woodward; Xiaoming Xie; Hirohito Yamaguchi; Dihua Yu; Yi Bao; Chun-Ju Chang; Gabriel N Hortobagyi; Jennifer L Hsu; Mien-Chie Hung
BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.
Cancer cell 2011;20(3):341-56.
2011: Merih Guray Durak; Ana M Gonzalez-Angulo; Emer O Hanrahan; Gabriel N Hortobagyi; Kelly K Hunt; Kristine Broglio; Vicente Valero; Aysegul A Sahin
Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.
The breast journal 2011;17(5):462-9.
2011: Antonio Giordano; Mario Giuliano; Kenneth Hess; Gabriel N Hortobagyi; Francesco Iorio; Lajos Pusztai; Massimo Cristofanilli; Michelino De Laurentiis; Sabino De Placido; Antonio Eleuteri; Roberto Tagliaferri; James M Reuben
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.
Breast cancer research and treatment 2011;129(2):451-8.
2011: Huong T Le-Petross; Jennifer K Litton; Gary J Whitman; Ying Yuan; Deanne P Atchley; Angelica Gutierrez-Barrera; Gabriel N Hortobagyi; Banu K Arun
Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Cancer 2011;117(17):3900-7.
2011: Abigail S Caudle; Barry W Feig; Karen Hoffman; Gabriel N Hortobagyi; Kelly K Hunt; Rosa F Hwang; Henry M Kuerer; Jennifer K Litton; Anthony Lucci; Funda Meric-Bernstam; Gildy V Babiera; Isabelle Bedrosian; Thomas A Buchholz; Merrick I Ross; Aysegul A Sahin; Wei Yang; Elizabeth A Mittendorf
Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.
Annals of surgical oncology 2011;18(9):2407-12.
2011: Donald A Berry; Marco Bregni; Jean Caputo; R Charles Coombes; John P Crown; Elisabeth G E de Vries; William E Barlow; Russell L Basser; Jonas Bergh; ALESSANDRO MASSIMO GIANNI; Gabriel N Hortobagyi; Marcella M Johnson; Xiudong Lei; Robert C Leonard; Ulrike A Nitz; Paolo Pedrazzoli; William P Peters; Henri Roché; Sjoerd Rodenhuis; Martin S Tallman; Yutaka Tokuda; Naoto T Ueno; Axel R Zander; Taner Demirer
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3214-23.
2011: Mariana Chavez-MacGregor; Shenying Fang; Gabriel N Hortobagyi; Tomasz P Srokowski; Hui Zhao; Sharon H Giordano
Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study.
Cancer 2011;117(16):3641-9.
2011: Phuong K Morrow; Rodolfo Nuñez; Aysegul A Sahin; Eric P Winer; Gerburg M Wulf; Yan Xiong; Dihua Yu; Siyuan Zhang; Daniel J Booser; Jeanna Coviello; Joe Ensor; Peter R Flores; Gabriel N Hortobagyi; David W Kindelberger; Ian Krop; Julia A Moore; Francisco J Esteva
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3126-32.
2011: Chun-Te Chen; Yi Du; Gabriel N Hortobagyi; Jennifer L Hsu; Heng-Huan Lee; Hong-Jen Lee; Hui-Lung Sun; Yan Wang; Weiya Xia; Hirohito Yamaguchi; Edward T H Yeh; Chia-Jui Yen; Wen-Hsuan Yu; Mien-Chie Hung
Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.
Molecular cancer therapeutics 2011;10(8):1327-36.
2011: Amal Melhem-Bertrandt; Funda Meric-Bernstam; Anil K Sood; Gabriel N Hortobagyi; Richard T Lee; Xiudong Lei; Erika N Brown; Mariana Chavez-Macgregor; Suzanne D Conzen; Ana-Maria Gonzalez-Angulo
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2645-52.
2011: Leonel F Hernandez-Aya; Gabriel N Hortobagyi; Limin Hsu; Xiudong Lei; Funda Meric-Bernstam; Aysegul A Sahin; Vicente Valero; Thomas A Buchholz; Mariana Chavez-Macgregor; Kim-Anh Do; Ana Maria Gonzalez-Angulo
Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2628-34.
2011: James M Reuben; Xuemei Wang; Evan N Cohen; Massimo Cristofanilli; Hui Gao; Antonio Giordano; Gabriel N Hortobagyi; Savitri Krishnamurthy; Bang-Ning Lee; Ashutosh Lodhi; Anthony Lucci; Michel Mego; Wendy A Woodward
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.
European journal of cancer (Oxford, England : 1990) 2011;47(10):1527-36.
2011: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Lee M Ellis
Targeted therapies: peaking beneath the surface of recent bevacizumab trials.
Nature reviews. Clinical oncology 2011;8(6):319-20.
2011: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Shuying Liu; Ana Lluch; Juan A Barrera; Octavio Burgues; Huiqin Chen; Jaime Ferrer-Lozano; Gordon B Mills; Aysegul Sahin; Katherine Stemke-Hale; Funda Meric-Bernstam
PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.
Molecular cancer therapeutics 2011;10(6):1093-101.
2011: Elizabeth A Mittendorf; Jacqueline S Jeruss; Susan L Tucker; Aparna Kolli; Lisa A Newman; Ana M Gonzalez-Angulo; Thomas A Buchholz; Aysegul A Sahin; Janice N Cormier; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):1956-62.
2011: Christos Hatzis; Lajos Pusztai; Vicente Valero; Daniel J Booser; Laura Esserman; Ana Lluch; Tatiana Vidaurre; Frankie Holmes; Eduardo Souchon; Hongkun Wang; Miguel Martin; José Cotrina; Henry Gomez; Rebekah Hubbard; J Ignacio Chacón; Jaime Ferrer-Lozano; Richard Dyer; Meredith Buxton; Yun Gong; Yun Wu; Nuhad Ibrahim; Eleni Andreopoulou; Naoto T Ueno; Kelly Hunt; Wei Yang; Arlene Nazario; Angela DeMichele; Joyce O'Shaughnessy; Gabriel N Hortobagyi; W Fraser Symmans
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
JAMA : the journal of the American Medical Association 2011;305(18):1873-81.
2011: Shaheenah Dawood; Naoto T Ueno; Vicente Valero; Wendy A Woodward; Thomas A Buchholz; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo; Massimo Cristofanilli
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
Cancer 2011;117(9):1819-26.
2011: Charles Coutant; Roman Rouzier; Yuan Qi; Jacqueline Lehmann-Che; Giampaolo Bianchini; Takayuki Iwamoto; Gabriel N Hortobagyi; W Fraser Symmans; Serge Uzan; Fabrice Andre; Hugues de Thé; Lajos Pusztai
Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(8):2591-601.
2011: Siyuan Zhang; Wen-Chien Huang; Ping Li; Hua Guo; Say-Bee Poh; Samuel W Brady; Yan Xiong; Ling-Ming Tseng; Shau-Hsuan Li; Zhaoxi Ding; Aysegul A Sahin; Francisco J Esteva; Gabriel N Hortobagyi; Dihua Yu
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways.
Nature medicine 2011;17(4):461-9.
2011: Abigail S Caudle; Ana M Gonzalez-Angulo; Kelly K Hunt; Lajos Pusztai; Henry M Kuerer; Elizabeth A Mittendorf; Gabriel N Hortobagyi; Funda Meric-Bernstam
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.
Annals of surgical oncology 2011;18(4):932-8.
2011: Georgiana K Ellis; William E Barlow; Julie R Gralow; Gabriel N Hortobagyi; Christy A Russell; Melanie E Royce; Edith A Perez; Danika Lew; Robert B Livingston
Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(8):1014-21.
2011: Gabriel N Hortobagyi
Commentary: role of bone-modifying agents in metastatic breast cancer.
Journal of oncology practice / American Society of Clinical Oncology 2011;7(2):121-3.
2011: Ana M Gonzalez-Angulo; Kirsten M Timms; Shuying Liu; Huiqin Chen; Jennifer K Litton; Jennifer Potter; Jerry S Lanchbury; Katherine Stemke-Hale; Bryan T. J. Hennessy; Banu K Arun; Gabriel N Hortobagyi; Kim-Anh Do; Gordon B Mills; Funda Meric-Bernstam
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(5):1082-9.
2011: Takayuki Iwamoto; Giampaolo Bianchini; Daniel J Booser; Yuan Qi; Charles Coutant; Christine Ya-Hui Shiang; Libero Santarpia; Junji Matsuoka; Gabriel N Hortobagyi; W Fraser Symmans; Frankie A Holmes; Joyce A O'Shaughnessy; Beth Hellerstedt; John Pippen; Fabrice Andre; Richard Simon; Lajos Pusztai
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Journal of the National Cancer Institute 2011;103(3):264-72.
2011: Takayuki Iwamoto; Giampaolo Bianchini; Yuan Qi; Massimo Cristofanilli; Anthony Lucci; Wendy A Woodward; James M Reuben; Junji Matsuoka; Yun Gong; Savitri Krishnamurthy; Vicente Valero; Gabriel N Hortobagyi; Fredika Robertson; W Fraser Symmans; Lajos Pusztai; Naoto T Ueno
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
Breast cancer research and treatment 2011;125(3):785-95.
2011: Henri Roché; Pierfranco Conte; Edith A Perez; Joseph A Sparano; Binghe Xu; Jacek Jassem; Ronald Peck; Thomas Kelleher; Gabriel N Hortobagyi
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.
Breast cancer research and treatment 2011;125(3):755-65.
2011: Ana O Hoff; Bela Toth; Mimi Hu; Gabriel N Hortobagyi; Robert F Gagel
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.
Annals of the New York Academy of Sciences 2011;1218():47-54.
2011: Chun-Ju Chang; Jer-Yen Yang; Weiya Xia; Chun-Te Chen; Xiaoming Xie; Chi-Hong Chao; Wendy A Woodward; Jung-Mao Hsu; Gabriel N Hortobagyi; Mien-Chie Hung
EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
Cancer cell 2011;19(1):86-100.
2011: Phuong Khanh H Morrow; Danielle N Mattair; Gabriel N Hortobagyi
Hot flashes: a review of pathophysiology and treatment modalities.
The oncologist 2011;16(11):1658-64.
2011: Banu K Arun; Daniel Booser; Kristine Broglio; Aman U Buzdar; Kapil Dhinghra; Debbie Frye; Laura Guerra; Nuhad Ibrahim; Shu-Wan Kau; Merrick Ross; Aysegul Sahin; Nour Sneige; Eric Strom; Richard L Theriault; Saroj Vadhan-Raj; Vicente Valero; Ronald Walters; Guosheng Yin; Gabriel N Hortobagyi
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.
The oncologist 2011;16(11):1527-34.
2011: Ana M Gonzalez-Angulo; Bryan T Hennessy; Gabriel N Hortobagyi; Zhenlin Ju; Wenbin Liu; Ana Lluch; Funda Meric-Bernstam; Jan Alsner; Sam Aparicio; Anne-Lise Borresen-Dale; Russell Broaddus; Powel Brown; Mark S Carey; Kevin R Coombes; Lei Deng; Simen Myhre; Jens Overgaard; Lajos Pusztai; Aysegul Sahin; Corey Speers; W Fraser Symmans; Gordon B Mills
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer.
Clinical proteomics 2011;8(1):11.
2011: Patricia A Thompson; Spyros Tsavachidis; Yuker Wang; Li Zhang; Veerabhadran Baladandayuthapani; Abenaa M Brewster; Bradley M Broom; Mary E Edgerton; Klaus M Hahn; Gabriel N Hortobagyi; Do Kim-Anh; Gordon B Mills; James L Murray; Aysegul Sahin; Melissa L Bondy
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.
PloS one 2011;6(8):e23543.
2011: Chandra Bartholomeusz; Gabriel N Hortobagyi; Kaoru Kurisu; Hitomi Saso; Fumiyuki Yamasaki; Naoto T Ueno
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt.
Journal of Cancer 2011;2():435-42.
2011: Naoki Niikura; Shana L Palla; Richard L Theriault; Yutaka Tokuda; Colleen M Costelloe; Naoki Hayashi; Gabriel N Hortobagyi; Jun Liu; John E Madewell; Tse-Kuan Yu; Naoto T Ueno
FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer.
The oncologist 2011;16(8):1111-9.
2011: Mario Giuliano; Beverly C Handy; Kenneth R Hess; Gabriel N Hortobagyi; Summer Jackson; Michal Mego; James M Reuben; Naoto T Ueno; Vicente Valero; Ugo De Giorgi; Michelino De Laurentiis; Sabino De Placido; Antonio Giordano; Ricardo H Alvarez; Massimo Cristofanilli
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.
Breast cancer research : BCR 2011;13(3):R67.
2011: Naoki Niikura; Shana L Palla; Richard L Theriault; Yutaka Tokuda; Colleen M Costelloe; Naoki Hayashi; Gabriel N Hortobagyi; Jun Liu; John E Madewell; Tse-Kuan Yu; Naoto T Ueno
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
The oncologist 2011;16(6):772-82.
2011: Carlo La Vecchia; Sharon H Giordano; Gabriel N Hortobagyi; Bruce Chabner
Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.
The oncologist 2011;16(6):726-9.
2011: Ricardo H Alvarez; Vicente Valero; Gabriel N Hortobagyi
Ixabepilone for the treatment of breast cancer.
Annals of medicine 2011;43(6):477-86.
2011: Naoki Niikura; Jun Liu; Naoki Hayashi; Shana L Palla; Yutaka Tokuda; Gabriel N Hortobagyi; Naoto T Ueno; Richard L Theriault
Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.
The oncologist 2011;16(2):155-64.
2010: Song Yao; William E Barlow; Kathy S Albain; Ji-Yeob Choi; Hua Zhao; Robert B Livingston; Warren Davis; James M Rae; I-Tien Yeh; Laura F Hutchins; Peter M Ravdin; Silvana Martino; Alan P Lyss; C Kent Osborne; Martin D Abeloff; Gabriel N Hortobagyi; Daniel F Hayes; Christine B Ambrosone
Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(24):6169-76.
2010: Ricardo H Alvarez; Gabriel N Hortobagyi
Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.
Breast cancer research and treatment 2010;124(3):701-5.
2010: Shaheenah Dawood; Naoto T Ueno; Vicente Valero; Eleni Andreopoulou; L Hsu; J Lara; Wendy A Woodward; Thomas Buchholz; Gabriel N Hortobagyi; Massimo Cristofanilli
Incidence of and survival following brain metastases among women with inflammatory breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(12):2348-55.
2010: Gabriel N Hortobagyi
Why my neighbor's health is important to me.
Oncology (Williston Park, N.Y.) 2010;24(13):1238.
2010: Ke Liang; Francisco J Esteva; Constance Albarracin; Katherine Stemke-Hale; Yang Lu; Giampaolo Bianchini; Ching-Yi Yang; Yong Li; Xinqun Li; Chun-Te Chen; Gordon B Mills; Gabriel N Hortobagyi; John Mendelsohn; Mien-Chie Hung; Zhen Fan
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
Cancer cell 2010;18(5):423-35.
2010: Catherine M Kelly; Savitri Krishnamurthy; Giampaolo Bianchini; Jennifer K Litton; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Lajos Pusztai
Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.
Cancer 2010;116(22):5161-7.
2010: Dongwei Zhang; Ana M Tari; Ugur Akar; Banu Arun; Tiffany A Lafortune; Rene Nieves-Alicea; Gabriel N Hortobagyi; Naoto T Ueno
Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer.
Molecular cancer therapeutics 2010;9(11):3090-9.
2010: Giampaolo Bianchini; Takayuki Iwamoto; Yuan Qi; Charles Coutant; Christine Y Shiang; Bailang Wang; Libero Santarpia; Vicente Valero; Gabriel N Hortobagyi; W Fraser Symmans; Luca Gianni; Lajos Pusztai
Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer.
Cancer research 2010;70(21):8852-62.
2010: Adel Tabchy; Vicente Valero; Tatiana Vidaurre; Ana Lluch; Henry Gomez; Miguel Martin; Yuan Qi; Luis Javier Barajas-Figueroa; Eduardo Souchon; Charles Coutant; Franco D Doimi; Nuhad K Ibrahim; Yun Gong; Gabriel N Hortobagyi; Kenneth R Hess; W Fraser Symmans; Lajos Pusztai
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(21):5351-61.
2010: Tomifumi Onishi; Naoki Hayashi; Richard L Theriault; Gabriel N Hortobagyi; Naoto T Ueno
Future directions of bone-targeted therapy for metastatic breast cancer.
Nature reviews. Clinical oncology 2010;7(11):641-51.
2010: Shivani S Shinde; Michele R Forman; Henry M Kuerer; Kai Yan; Florentia Peintinger; Kelly K Hunt; Gabriel N Hortobagyi; Lajos Pusztai; W Fraser Symmans
Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer.
Cancer 2010;116(21):4933-43.
2010: Shaheenah Dawood; Kristine Broglio; Joe Ensor; Gabriel N Hortobagyi; Sharon H Giordano
Survival differences among women with de novo stage IV and relapsed breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2169-74.
2010: Song Yao; William E Barlow; Kathy S Albain; Ji-Yeob Choi; Hua Zhao; Robert B Livingston; Warren Davis; James M Rae; I-Tien Yeh; Laura F Hutchins; Peter M Ravdin; Silvana Martino; Alan P Lyss; C Kent Osborne; Martin D Abeloff; Gabriel N Hortobagyi; Daniel F Hayes; Christine B Ambrosone
Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Breast cancer research and treatment 2010;124(2):433-9.
2010: Y C Cheng; V Valero; M L Davis; M C Green; A M Gonzalez-Angulo; Richard L Theriault; James L Murray; Gabriel N Hortobagyi; Naoto T Ueno
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients.
British journal of cancer 2010;103(9):1331-4.
2010: H Yamaguchi; C-T Chen; C-K Chou; A Pal; W Bornmann; Gabriel N Hortobagyi; Mien-Chie Hung
Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation.
Oncogene 2010;29(41):5619-29.
2010: Francisco J Esteva; Hua Guo; Siyuan Zhang; Cesar Santa-Maria; Steven Stone; Jerry S Lanchbury; Aysegul A Sahin; Gabriel N Hortobagyi; Dihua Yu
PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.
The American journal of pathology 2010;177(4):1647-56.
2010: Giampaolo Bianchini; Yuan Qi; Ricardo H Alvarez; Takayuki Iwamoto; Charles Coutant; Nuhad K Ibrahim; Vicente Valero; Massimo Cristofanilli; Marjorie C Green; Laszlo Radvanyi; Christos Hatzis; Gabriel N Hortobagyi; Fabrice Andre; Luca Gianni; W Fraser Symmans; Lajos Pusztai
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4316-23.
2010: Phuong K Morrow; Stephen Divers; Louise Provencher; Shiuh-Wen Luoh; Teresa M Petrella; Marius Giurescu; Thomas Schmelter; Yao Wang; Gabriel N Hortobagyi; Linda Vahdat
Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.
Breast cancer research and treatment 2010;123(3):837-42.
2010: Christine Y Shiang; Yuan Qi; Bailiang Wang; Vladimir Lazar; Jing Wang; W Fraser Symmans; Gabriel N Hortobagyi; Fabrice Andre; Lajos Pusztai
Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Breast cancer research and treatment 2010;123(3):747-55.
2010: W Fraser Symmans; Christos Hatzis; Christos Sotiriou; Fabrice Andre; Florentia Peintinger; Peter Regitnig; Guenter Daxenbichler; Christine Desmedt; Julien Domont; Christian Marth; Suzette Delaloge; Thomas Bauernhofer; Vicente Valero; Daniel J Booser; Gabriel N Hortobagyi; Lajos Pusztai
Genomic index of sensitivity to endocrine therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4111-9.
2010: Mariana Chavez-Macgregor; Jennifer Litton; Huiqin Chen; Sharon H Giordano; Clifford Hudis; Antonio C Wolff; Vicente Valero; Gabriel N Hortobagyi; Melissa L Bondy; Ana M Gonzalez-Angulo
Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity.
Cancer 2010;116(17):4168-77.
2010: Ugo De Giorgi; Michal Mego; Eric M Rohren; Ping Liu; Beverly C Handy; James M Reuben; Homer A Macapinlac; Gabriel N Hortobagyi; Massimo Cristofanilli; Naoto T Ueno
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(8):1213-8.
2010: Jeffrey M Albert; Ana M Gonzalez-Angulo; Merih Guray; Aysegul Sahin; Eric A Strom; Welela Tereffe; Wendy A Woodward; Susan L Tucker; Kelly K Hunt; Gabriel N Hortobagyi; Thomas Buchholz
Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
International journal of radiation oncology, biology, physics 2010;77(5):1296-302.
2010: Ricardo H Alvarez; Vicente Valero; Gabriel N Hortobagyi
Emerging targeted therapies for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3366-79.
2010: Catherine M Kelly; Gabriel N Hortobagyi
Adjuvant chemotherapy in early-stage breast cancer: what, when, and for whom?
Surgical oncology clinics of North America 2010;19(3):649-68.
2010: Shaheenah Dawood; Ana M Gonzalez-Angulo; Constance Albarracin; Tse-Kuan Yu; Gabriel N Hortobagyi; Thomas A Buchholz; Wendy A Woodward
Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review.
Cancer 2010;116(13):3084-92.
2010: Gabriel N Hortobagyi; Henry L Gomez; Rubi K Li; Hyun-Cheol Chung; Luis E Fein; Valorie F Chan; Jacek Jassem; Guillermo L Lerzo; Xavier B Pivot; Fernando Hurtado de Mendoza; Binghe Xu; Linda Vahdat; Ronald A Peck; Pralay Mukhopadhyay; Henri Roché
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
Breast cancer research and treatment 2010;122(2):409-18.
2010: Gabriel N Hortobagyi; Powel H Brown
Two good choices to prevent breast cancer: great taste, less filling.
Cancer prevention research (Philadelphia, Pa.) 2010;3(6):681-5.
2010: Jer-Yen Yang; Chun-Ju Chang; Weiya Xia; Yan Wang; Kwok-Kin Wong; Jeffrey A Engelman; Yi Du; Michael Andreeff; Gabriel N Hortobagyi; Mien-Chie Hung
Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
Cancer research 2010;70(11):4709-18.
2010: Banu Arun; Laura A Granville; Guosheng Yin; Lavinia P Middleton; Shaheenah Dawood; Shu-Wan Kau; Arif Kamal; Limin Hsu; Gabriel N Hortobagyi; Aysegul A Sahin
Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy.
Cancer investigation 2010;28(5):554-9.
2010: Cornelia Liedtke; Jing Wang; Attila Tordai; William F Symmans; Gabriel N Hortobagyi; Ludwig Kiesel; Kenneth Hess; Keith A Baggerly; Kevin R Coombes; Lajos Pusztai
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.
Breast cancer research and treatment 2010;121(2):301-9.
2010: Gabriel N Hortobagyi; Robyn R Young; Mark Karwal; Nuhad K Ibrahim; Robert Hermann; James L Murray; Stanley P Watkins; Ira Gore
A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
Cancer 2010;116(10):2301-6.
2010: Stacy Moulder; Kai Yan; Fei Huang; Kenneth R Hess; Cornelia Liedtke; Feng Lin; Christos Hatzis; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Development of candidate genomic markers to select breast cancer patients for dasatinib therapy.
Molecular cancer therapeutics 2010;9(5):1120-7.
2010: Ugur Akar; Bulent Ozpolat; Kapil Mehta; Gabriel Lopez-Berestein; Dongwei Zhang; Naoto T Ueno; Gabriel N Hortobagyi; Banu Arun
Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model.
Molecular cancer therapeutics 2010;9(5):1180-7.
2010: James M Reuben; Bang-Ning Lee; Changping Li; Hui Gao; Kristine Broglio; Vicente Valero; Summer A Jackson; Naoto T Ueno; Savitri Krishnamurthy; Gabriel N Hortobagyi; Massimo Cristofanilli
Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.
The breast journal 2010;16(3):327-30.
2010: Olivier Graesslin; Bassam S Abdulkarim; Charles Coutant; Florence Huguet; Zsolt Gabos; Limin Hsu; Olivier Marpeau; Serge Uzan; Lajos Pusztai; Eric A Strom; Gabriel N Hortobagyi; Roman Rouzier; Nuhad K Ibrahim
Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2032-7.
2010: Abigail S Caudle; Ana M Gonzalez-Angulo; Kelly K Hunt; Ping Liu; Lajos Pusztai; W Fraser Symmans; Henry M Kuerer; Elizabeth A Mittendorf; Gabriel N Hortobagyi; Funda Meric-Bernstam
Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1821-8.
2010: Huong Le-Petross; Vikas Kundra; Janio Szklaruk; Wei Wei; Gabriel N Hortobagyi; Jingfei Ma
Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI.
Journal of magnetic resonance imaging : JMRI 2010;31(4):889-94.
2010: Malini Harigopal; William E Barlow; Greg Tedeschi; Peggy L Porter; I-Tien Yeh; Charles Haskell; Robert Livingston; Gabriel N Hortobagyi; George Sledge; Charles Shapiro; James N Ingle; David L Rimm; Daniel F Hayes
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.
The American journal of pathology 2010;176(4):1639-47.
2010: Joseph A Sparano; Etta D Pisano; Julia R White; Kelly K Hunt; Eleftherios P Mamounas; Edith A Perez; Gabriel N Hortobagyi; Julie R Gralow; Robert L Comis
Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.
Breast cancer research and treatment 2010;120(2):273-84.
2010: Chandra Bartholomeusz; Ana M Gonzalez-Angulo; Anna Kazansky; Savitri Krishnamurthy; Ping Liu; Linda X H Yuan; Fumiyuki Yamasaki; Shuying Liu; Naoki Hayashi; Dongwei Zhang; Francisco J Esteva; Gabriel N Hortobagyi; Naoto T Ueno
PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(6):1802-11.
2010: Gabriel N Hortobagyi; William Heim; Laura Hutchins; Edgardo Rivera; Bernard Mason; Daniel J Booser; Jeffrey J Kirshner
A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
Cancer 2010;116(6):1440-5.
2010: Ricardo H Alvarez; Daniel J Booser; Massimo Cristofanilli; Aysegul A Sahin; Eric A Strom; Laura Guerra; Shu-Wan Kau; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Vicente Valero
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
Cancer 2010;116(5):1210-7.
2010: T Hamaoka; Colleen M Costelloe; John E Madewell; P Liu; D A Berry; R Islam; Richard L Theriault; Gabriel N Hortobagyi; Naoto T Ueno
Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer.
British journal of cancer 2010;102(4):651-7.
2010: Stacy L Moulder; Frankie A Holmes; Anthony W Tolcher; Peter F Thall; Kristine Broglio; Vicente Valero; Aman U Buzdar; Susan G Arbuck; Andrew D Seidman; Gabriel N Hortobagyi
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.
Cancer 2010;116(4):814-21.
2010: Francisco J Esteva; Dihua Yu; Mien-Chie Hung; Gabriel N Hortobagyi
Molecular predictors of response to trastuzumab and lapatinib in breast cancer.
Nature reviews. Clinical oncology 2010;7(2):98-107.
2010: Joseph A Sparano; Gabriel N Hortobagyi; Julie R Gralow; Edith A Perez; Robert L Comis
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization.
Breast cancer research and treatment 2010;119(3):511-27.
2010: Quanri Jin; Linda X Yuan; Delphine Boulbes; Jong Min Baek; Ying-Nai Wang; Daniel Gomez-Cabello; David H Hawke; Sai Ching Yeung; Mong-Hong Lee; Gabriel N Hortobagyi; Mien-Chie Hung; Francisco J Esteva
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
Breast cancer research : BCR 2010;12(6):R96.
2010: Laura S Dominici; Henry M Kuerer; Gildy V Babiera; Karin M E Hahn; George Perkins; Lavinia Middleton; Mildred M Ramirez; Wei Yang; Gabriel N Hortobagyi; Richard L Theriault; Jennifer K Litton
Wound complications from surgery in pregnancy-associated breast cancer (PABC).
Breast disease 2010;31(1):1-5.
2010: Fabrice Andre; Kristine Broglio; Lajos Pusztai; Narjiss Berrada; John R Mackey; Jean-Marc Nabholtz; Stephen Chan; Gabriel N Hortobagyi
Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trials.
The oncologist 2010;15(5):476-83.
2010: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Brain metastases and breast cancer subtypes.
Onkologie 2010;33(4):143-4.
2010: Vlad Popovici; Weijie Chen; Brandon G Gallas; Christos Hatzis; Weiwei Shi; Frank W Samuelson; Yuri Nikolsky; Marina Tsyganova; Alex Ishkin; Tatiana Nikolskaya; Kenneth R Hess; Vicente Valero; Daniel Booser; Mauro Delorenzi; Gabriel N Hortobagyi; Leming Shi; W Fraser Symmans; Lajos Pusztai
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors.
Breast cancer research : BCR 2010;12(1):R5.
2010: Kathy S Albain; William E Barlow; Steven Shak; Gabriel N Hortobagyi; Robert B Livingston; I-Tien Yeh; Peter M Ravdin; Roberto Bugarini; Frederick L Baehner; Nancy E Davidson; George W Sledge; Eric P Winer; Clifford Hudis; James N Ingle; Edith A Perez; Kathleen I Pritchard; Lois Shepherd; Julie R Gralow; Carl Yoshizawa; D Craig Allred; C Kent Osborne; Daniel F Hayes
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
The lancet oncology 2010;11(1):55-65.
2010: Shaheenah Dawood; Kristine Broglio; Aman U Buzdar; Gabriel N Hortobagyi; Sharon H Giordano
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):92-8.
2010: Marilyn L Slovak; Victoria Bedell; Danika Lew; Kathy S Albain; Georgiana K Ellis; Robert B Livingston; Silvana Martino; Edith A Perez; Gabriel N Hortobagyi; Dorie Sher; Wendy Stock
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).
Breast cancer research and treatment 2010;119(2):391-8.
2010: U De Giorgi; Vicente Valero; Eric M Rohren; M Mego; Gerald V Doyle; M Craig Miller; Naoto T Ueno; Beverly C Handy; James M Reuben; Homer A Macapinlac; Gabriel N Hortobagyi; Massimo Cristofanilli
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):33-9.
2010: Wei Tse Yang; Michael Lewis; Kenneth Hess; Helen Wong; Anna Tsimelzon; Nese Karadag; Michelina Cairo; Caimaio Wei; Funda Meric-Bernstam; Powel Brown; Banu Arun; Gabriel N Hortobagyi; Aysegul Sahin; Jenny C Chang
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.
Breast cancer research and treatment 2010;119(2):305-14.
2009: vincent vinh-hung; Nam P Nguyen; Gábor Cserni; Pauline Truong; Wendy Woodward; Helena M Verkooijen; Donald Promish; Naoto T Ueno; Patricia Tai; Yago Nieto; Sue Joseph; Wolfgang Janni; Frank Vicini; Melanie Royce; Guy Storme; Anne-Marie Wallace; Georges Vlastos; Christine Bouchardy; Gabriel N Hortobagyi
Prognostic value of nodal ratios in node-positive breast cancer: a compiled update.
Future oncology (London, England) 2009;5(10):1585-603.
2009: Fabrice Andre; Weiya Xia; R Conforti; Yongkun Wei; Thomas Boulet; Gorana Tomasic; Marc Spielmann; Moustafa Zoubir; Narjiss Berrada; Rodrigo Arriagada; Gabriel N Hortobagyi; Mien-Chie Hung; Lajos Pusztai; Suzette Delaloge; Stefan Michiels; Massimo Cristofanilli
CXCR4 expression in early breast cancer and risk of distant recurrence.
The oncologist 2009;14(12):1182-8.
2009: Elizabeth A Mittendorf; Yun Wu; Maurizio Scaltriti; Funda Meric-Bernstam; Kelly K Hunt; Shaheenah Dawood; Francisco J Esteva; Aman U Buzdar; Huiqin Chen; Sameena Eksambi; Gabriel N Hortobagyi; Jose Baselga; Ana M Gonzalez-Angulo
Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7381-8.
2009: Ana M Gonzalez-Angulo; Jennifer K Litton; Kristine Broglio; Funda Meric-Bernstam; Ronjay Rakkhit; Fatima Cardoso; Florentia Peintinger; Emer O Hanrahan; Aysegul Sahin; Merih Guray; Denis Larsimont; Francesco Feoli; Heidi Stranzl; Thomas A Buchholz; Vicente Valero; Richard Theriault; Martine Piccart-Gebhart; Peter M Ravdin; Donald A Berry; Gabriel N Hortobagyi
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):5700-6.
2009: C Liedtke; Kristine Broglio; S Moulder; L Hsu; Shu-Wan Kau; W Fraser Symmans; Constance T Albarracin; Funda Meric-Bernstam; Wendy A Woodward; Richard L Theriault; L Kiesel; Gabriel N Hortobagyi; Lajos Pusztai; Ana M Gonzalez-Angulo
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(12):1953-8.
2009: Dongwei Zhang; Tiffany A Lafortune; Savitri Krishnamurthy; Francisco J Esteva; Massimo Cristofanilli; Ping Liu; Anthony Lucci; Balraj Singh; Mien-Chie Hung; Gabriel N Hortobagyi; Naoto T Ueno
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6639-48.
2009: Grace L Smith; Ying Xu; Ya-Chen T Shih; Sharon H Giordano; Benjamin David Smith; Kelly K Hunt; Eric A Strom; George H Perkins; Gabriel N Hortobagyi; Thomas A Buchholz
Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.
Journal of the American College of Surgeons 2009;209(4):425-433.e2.
2009: Luca Gianni; Larry Norton; Norman Wolmark; Thomas M Suter; Gianni Bonadonna; Gabriel N Hortobagyi
Role of anthracyclines in the treatment of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4798-808.
2009: Lajos Pusztai; Jong-Hyeon Jeong; Yun Gong; Jeffrey S Ross; Chungyeul Kim; Soonmyung Paik; Roman Rouzier; Fabrice Andre; Gabriel N Hortobagyi; Norman Wolmark; W Fraser Symmans
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4287-92.
2009: Naoto T Ueno; Jonas A de Souza; Daniel Booser; Kazutaka Nakayama; John Madewell; Richard E Wendt; Gabriel N Hortobagyi; Donald Podoloff; Richard E Champlin
Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer.
Clinical breast cancer 2009;9(3):173-7.
2009: Francisco J Esteva; Gabriel N Hortobagyi
Topoisomerase II{alpha} amplification and anthracycline-based chemotherapy: the jury is still out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3416-7.
2009: Sao Jiralerspong; Shana L Palla; Sharon H Giordano; Funda Meric-Bernstam; Cornelia Liedtke; Chad M Barnett; Limin Hsu; Mien-Chie Hung; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3297-302.
2009: Ugo De Giorgi; Vicente Valero; Eric M Rohren; Shaheenah Dawood; Naoto T Ueno; M Craig Miller; Gerald V Doyle; Summer Jackson; Eleni Andreopoulou; Beverly C Handy; James M Reuben; Herbert A Fritsche; Homer A Macapinlac; Gabriel N Hortobagyi; Massimo Cristofanilli
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3303-11.
2009: Hideko Yamauchi; Massimo Cristofanilli; Seigo Nakamura; Gabriel N Hortobagyi; Naoto T Ueno
Molecular targets for treatment of inflammatory breast cancer.
Nature reviews. Clinical oncology 2009;6(7):387-94.
2009: Cornelia Liedtke; Christos Hatzis; W Fraser Symmans; Christine Desmedt; Benjamin Haibe-Kains; Vicente Valero; Henry M Kuerer; Gabriel N Hortobagyi; Martine Piccart-Gebhart; Christos Sotiriou; Lajos Pusztai
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3185-91.
2009: Jing Lu; Patricia S Steeg; Janet E Price; Savitri Krishnamurthy; Sendurai Mani; James Reuben; Massimo Cristofanilli; gabriela dontu; Luc Bidaut; Vicente Valero; Gabriel N Hortobagyi; Dihua Yu
Breast cancer metastasis: challenges and opportunities.
Cancer research 2009;69(12):4951-3.
2009: Benjamin David Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Future of cancer incidence in the United States: burdens upon an aging, changing nation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2758-65.
2009: Colleen M Costelloe; Eric M Rohren; John E Madewell; Tsuyoshi Hamaoka; Richard L Theriault; Tse-Kuan Yu; Valerae O Lewis; Jingfei Ma; R Jason Stafford; Ana M Tari; Gabriel N Hortobagyi; Naoto T Ueno
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.
The lancet oncology 2009;10(6):606-14.
2009: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Katherine Stemke-Hale; Michael Z Gilcrease; Savitri Krishnamurthy; Ju-Seog Lee; Jane Fridlyand; Aysegul Sahin; Roshan Agarwal; Corwin Joy; Wenbin Liu; David N Stivers; Keith A Baggerly; Mark Carey; Ana Lluch; Carlos Monteagudo; Xiaping He; Victor Weigman; Cheng Fan; Juan Palazzo; Gabriel N Hortobagyi; Laura K Nolden; Nicholas J Wang; Vicente Valero; Joe Gray; Charles M Perou; Gordon B Mills
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
Cancer research 2009;69(10):4116-24.
2009: Jingfei Ma; Colleen M Costelloe; John E Madewell; Gabriel N Hortobagyi; Marjorie C Green; Guang Cao; Fei Sun; Vikas Kundra
Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases.
Journal of magnetic resonance imaging : JMRI 2009;29(5):1154-62.
2009: Tomasz P Srokowski; Shenying Fang; Gabriel N Hortobagyi; Sharon H Giordano
Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2170-6.
2009: Jennifer K Litton; Shannon N Westin; Kaylene Ready; Charlotte C Sun; Susan K Peterson; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Diane C Bodurka; Karen H Lu; Gabriel N Hortobagyi; Banu Arun
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
Cancer 2009;115(8):1598-604.
2009: Jeffrey S Ross; Elzbieta A Slodkowska; W Fraser Symmans; Lajos Pusztai; Peter M Ravdin; Gabriel N Hortobagyi
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
The oncologist 2009;14(4):320-68.
2009: Ana M Gonzalez-Angulo; Katherine Stemke-Hale; Shana L Palla; Mark Carey; Roshan Agarwal; Funda Meric-Berstam; Tiffany A Traina; Clifford Hudis; Gabriel N Hortobagyi; William L Gerald; Gordon B Mills; Bryan T. J. Hennessy
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2472-8.
2009: Shaheenah Dawood; Kristine Broglio; Francisco J Esteva; W Yang; Shu-Wan Kau; Rabiul Islam; Constance T Albarracin; Tse-Kuan Yu; Marjorie Green; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Survival among women with triple receptor-negative breast cancer and brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):621-7.
2009: Kaylene J Ready; Kristen J Vogel; Deann P Atchley; Kristine Broglio; Kimberly K Solomon; Christopher Amos; Karen H Lu; Gabriel N Hortobagyi; Banu Arun
Accuracy of the BRCAPRO model among women with bilateral breast cancer.
Cancer 2009;115(4):725-30.
2009: Banu Arun; Kristen J Vogel; Adriana Lopez; Mike Hernandez; Deann Atchley; Kristine Broglio; Christopher I Amos; Funda Meric-Bernstam; Henry Kuerer; Gabriel N Hortobagyi; Constance T Albarracin
High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.
Cancer prevention research (Philadelphia, Pa.) 2009;2(2):122-7.
2009: Fabrice Andre; Bastien Job; Philippe Dessen; Attila Tordai; Stefan Michiels; Cornelia Liedtke; Catherine Richon; Kai Yan; Bailang Wang; Gilles Vassal; Suzette Delaloge; Gabriel N Hortobagyi; W Fraser Symmans; Vladimir Lazar; Lajos Pusztai
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(2):441-51.
2009: Henry M Kuerer; Constance T Albarracin; Wei Tse Yang; Robert Cardiff; Abenaa M Brewster; W Fraser Symmans; Nola M Hylton; Lavinia P Middleton; Savitri Krishnamurthy; George H Perkins; Gildy Babiera; Mary E Edgerton; Brian J Czerniecki; Banu K Arun; Gabriel N Hortobagyi
Ductal carcinoma in situ: state of the science and roadmap to advance the field.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):279-88.
2009: Shaheenah Dawood; Kristine Broglio; Shu-Wan Kau; Marjorie C Green; Sharon H Giordano; Funda Meric-Bernstam; Thomas Buchholz; Constance T Albarracin; Wei Tse Yang; Bryan T. J. Hennessy; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):220-6.
2009: Phuong Khanh H Morrow; Gabriel N Hortobagyi
Management of breast cancer in the genome era.
Annual review of medicine 2009;60():153-65.
2009: Satoshi Nakayama; Yasuhiro Torikoshi; Takeshi Takahashi; Tomokazu Yoshida; Tamotsu Sudo; Tomoko Matsushima; Yuko Kawasaki; Aya Katayama; Keigo Gohda; Gabriel N Hortobagyi; Shinzaburo Noguchi; Toshiyuki Sakai; Hideki Ishihara; Naoto T Ueno
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells.
Breast cancer research : BCR 2009;11(1):R12.
2009: Yesim Eralp; Terry L Smith; Kadri Altundağ; Shu-Wan Kau; Jennifer Litton; Vicente Valero; Aman Buzdar; Gabriel N Hortobagyi; Banu Arun
Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.
Journal of cancer research and clinical oncology 2009;135(1):141-8.
2008: Stacy L Moulder; W Fraser Symmans; Daniel J Booser; Timothy L Madden; Cindy Lipsanen; Linda Yuan; Abenaa Brewster; Massimo Cristofanilli; Kelly K Hunt; Thomas Buchholz; James Zwiebel; Vicente Valero; Gabriel N Hortobagyi; Francisco J Esteva
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7909-16.
2008: Florentia Peintinger; Aman U Buzdar; Henry M Kuerer; Jaime A Mejia, M.D.; Christos Hatzis; Ana M Gonzalez-Angulo; Lajos Pusztai; Francisco J Esteva; S S Dawood; Marjorie C Green; Gabriel N Hortobagyi; W Fraser Symmans
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(12):2020-5.
2008: Shaheenah Dawood; Kristine Broglio; Vicente Valero; James M Reuben; Beverly Handy; Rabiul Islam; Summer Jackson; Gabriel N Hortobagyi; Herbert A Fritsche; Massimo Cristofanilli
Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
Cancer 2008;113(9):2422-30.
2008: Shaheenah Dawood; Kristine Broglio; Ana M Gonzalez-Angulo; Aman U Buzdar; Gabriel N Hortobagyi; Sharon H Giordano
Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4891-8.
2008: Nagi S El Saghir; Alexandru Eniu; Robert W Carlson; Zeba Aziz; Daniel Vorobiof; Gabriel N Hortobagyi
Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries.
Cancer 2008;113(8 Suppl):2315-24.
2008: Lajos Pusztai; Kristine Broglio; Fabrice Andre; W Fraser Symmans; Kenneth R Hess; Gabriel N Hortobagyi
Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4679-83.
2008: Massimo Cristofanilli; Paolo Morandi; Savitri Krishnamurthy; James M Reuben; Bang-Ning Lee; Deborah Francis; Daniel J Booser; Marjorie C Green; B K Arun; Lajos Pusztai; Adriana Lopez; Rabiul Islam; Vicente Valero; Gabriel N Hortobagyi
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1713-9.
2008: Ian J Bristol; Wendy A Woodward; Eric A Strom; Massimo Cristofanilli; Delora Domain; S Eva Singletary; George H Perkins; Julia L Oh; Tse-Kuan Yu; Welela Terrefe; Aysegul A Sahin; Kelly K Hunt; Gabriel N Hortobagyi; Thomas Buchholz
Locoregional treatment outcomes after multimodality management of inflammatory breast cancer.
International journal of radiation oncology, biology, physics 2008;72(2):474-84.
2008: Deann P Atchley; Constance T Albarracin; Adriana Lopez; Vicente Valero; Christopher I Amos; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Banu Arun
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4282-8.
2008: Jennifer K Litton; Ana M Gonzalez-Angulo; Carla L Warneke; Aman U Buzdar; Shu-Wan Kau; Melissa L Bondy; Somdat Mahabir; Gabriel N Hortobagyi; Abenaa M Brewster
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4072-7.
2008: Yongkun Wei; Weiya Xia; Zhihong Zhang; Jinsong Liu; Huamin Wang; Nazmi V Adsay; Constance Albarracin; Dihua Yu; James L Abbruzzese; Gordon B Mills; Robert C Bast; Gabriel N Hortobagyi; Mien-Chie Hung
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.
Molecular carcinogenesis 2008;47(9):701-6.
2008: Abenaa M Brewster; Gabriel N Hortobagyi; Kristine R Broglio; Shu-Wan Kau; Cesar A Santa-Maria; Banu Arun; Aman U Buzdar; Daniel J Booser; Vincente Valero; Melissa Bondy; Francisco J Esteva
Residual risk of breast cancer recurrence 5 years after adjuvant therapy.
Journal of the National Cancer Institute 2008;100(16):1179-83.
2008: Jacqueline S Jeruss; Elizabeth A Mittendorf; Susan L Tucker; Ana M Gonzalez-Angulo; Thomas A Buchholz; Aysegul A Sahin; Janice N Cormier; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Staging of breast cancer in the neoadjuvant setting.
Cancer research 2008;68(16):6477-81.
2008: Eleni Andreopoulou; Gabriel N Hortobagyi
Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3660-2.
2008: Daniel J Weisenberger; Binh N Trinh; Mihaela Campan; Shikhar Sharma; Tiffany I Long; Suchitra Ananthnarayan; Gangning Liang; Francisco J Esteva; Gabriel N Hortobagyi; Frank McCormick; Peter A Jones; Peter W Laird
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight.
Nucleic acids research 2008;36(14):4689-98.
2008: Thomas Buchholz; Wendy A Woodward; Zhigang Duan; Shenying Fang; Julia L Oh; Welela Tereffe; Eric A Strom; George H Perkins; Tse-Kuan Yu; Kelly K Hunt; Funda Meric-Bernstam; Gabriel N Hortobagyi; Sharon H Giordano
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.
International journal of radiation oncology, biology, physics 2008;71(4):1022-7.
2008: C Mazouni; B Arun; F André; M Ayers; S Krishnamurthy; B Wang; Gabriel N Hortobagyi; A U Buzdar; L Pusztai
Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers.
British journal of cancer 2008;99(1):68-71.
2008: Dongwei Zhang; Ashutosh Pal; William G Bornmann; Fumiyuki Yamasaki; Francisco J Esteva; Gabriel N Hortobagyi; Chandra Bartholomeusz; Naoto T Ueno
Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells.
Molecular cancer therapeutics 2008;7(7):1846-50.
2008: Tomasz P Srokowski; Shenying Fang; Zhigang Duan; Thomas Buchholz; Gabriel N Hortobagyi; James S Goodwin; Sharon H Giordano
Completion of adjuvant radiation therapy among women with breast cancer.
Cancer 2008;113(1):22-9.
2008: Shaheenah Dawood; Kristine Broglio; Francisco J Esteva; Nuhad K Ibrahim; Shu-Wan Kau; Rabiul Islam; Kenneth Aldape; Tse-Kuan Yu; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1242-8.
2008: Francisco J Esteva; Gabriel N Hortobagyi
Gaining ground on breast cancer.
Scientific American 2008;298(6):58-65.
2008: Ana O Hoff; Béla B Toth; Kadri Altundag; Marcella M Johnson; Carla L Warneke; Mimi Hu; Ajay Nooka; Gilbert Sayegh; Valentina Guarneri; Kimberly Desrouleaux; Jeffrey Cui; Andrea Adamus; Robert Gagel; Gabriel N Hortobagyi
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(6):826-36.
2008: Fabrice Andre; Kristine Broglio; Henri Roche; Miguel Martin; John R Mackey; Frederique Penault-Llorca; Gabriel N Hortobagyi; Lajos Pusztai
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2636-43.
2008: Sharon H Giordano; Yong-Fang Kuo; Zhigang Duan; Gabriel N Hortobagyi; Jean Freeman; James S Goodwin
Limits of observational data in determining outcomes from cancer therapy.
Cancer 2008;112(11):2456-66.
2008: Roshni Rao; Lei Feng; Henry M Kuerer; S Eva Singletary; Isabelle Bedrosian; Kelly K Hunt; Merrick I Ross; Gabriel N Hortobagyi; Barry W Feig; Frederick C Ames; Gildy V Babiera
Timing of surgical intervention for the intact primary in stage IV breast cancer patients.
Annals of surgical oncology 2008;15(6):1696-702.
2008: Wei Tse Yang; Huong T Le-Petross; Homer A Macapinlac; Selin Carkaci; Ana M Gonzalez-Angulo; Shaheenah Dawood; Erika Resetkova; Gabriel N Hortobagyi; Massimo Cristofanilli
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
Breast cancer research and treatment 2008;109(3):417-26.
2008: Brian D Badgwell; Sharon H Giordano; Zhigang Z Duan; Shenying Fang; Isabelle Bedrosian; Henry M Kuerer; S Eva Singletary; Kelly K Hunt; Gabriel N Hortobagyi; Gildy V Babiera
Mammography before diagnosis among women age 80 years and older with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2482-8.
2008: Sharon H Giordano; Shenying Fang; Zhigang Duan; Yong-Fang Kuo; Gabriel N Hortobagyi; James S Goodwin
Use of intravenous bisphosphonates in older women with breast cancer.
The oncologist 2008;13(5):494-502.
2008: Norazizah Shafee; Christopher R Smith; Shuanzeng Wei; Yoon Kim; Gordon B Mills; Gabriel N Hortobagyi; Eric J Stanbridge; Eva Y-H P Lee
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
Cancer research 2008;68(9):3243-50.
2008: W Fraser Symmans; Gabriel N Hortobagyi
Fingerprinting lymph node metastases.
Annals of surgical oncology 2008;15(5):1275-6.
2008: Shaheenah Dawood; Kristine Broglio; Yun Gong; Wei-Tse Yang; Massimo Cristofanilli; Shu-Wan Kau; Funda Meric-Bernstam; Thomas Buchholz; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Prognostic significance of HER-2 status in women with inflammatory breast cancer.
Cancer 2008;112(9):1905-11.
2008: Francisco J Esteva; Gabriel N Hortobagyi
Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
Journal of the National Cancer Institute 2008;100(8):521-3.
2008: Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Optimal schedule of paclitaxel: weekly is better.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1585-7.
2008: Edgardo Rivera; Jaime A Mejia, M.D.; Banu Arun; Rosnie B Adinin; Ronald S Walters; Abenaa Brewster; Kristine Broglio; Guosheng Yin; Bita Esmaeli; Gabriel N Hortobagyi; Vicente Valero
Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer.
Cancer 2008;112(7):1455-61.
2008: Shaheenah Dawood; Kristine Broglio; Ana M Gonzalez-Angulo; Shu-Wan Kau; Rabiul Islam; Gabriel N Hortobagyi; Massimo Cristofanilli
Prognostic value of body mass index in locally advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1718-25.
2008: Cornelia Liedtke; Chafika Mazouni; Kenneth R Hess; Fabrice André; Attila Tordai; Jaime A Mejia, M.D.; W Fraser Symmans; Ana M Gonzalez-Angulo; Bryan T. J. Hennessy; Marjorie Green; Massimo Cristofanilli; Gabriel N Hortobagyi; Lajos Pusztai
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1275-81.
2008: Fabrice Andre; Chafika Mazouni; Cornelia Liedtke; Shu-Wan Kau; Debby Frye; Marjorie Green; Ana M Gonzalez-Angulo; W Fraser Symmans; Gabriel N Hortobagyi; Lajos Pusztai
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.
Breast cancer research and treatment 2008;108(2):183-90.
2008: Sharon H Giordano; Gabriel N Hortobagyi
Time to remove the subspecialty blinders: breast cancer does not exist in isolation.
Journal of the National Cancer Institute 2008;100(4):230-1.
2008: Julie R Gralow; Harold J Burstein; William Wood; Gabriel N Hortobagyi; Luca Gianni; Gunter von Minckwitz; Aman U Buzdar; Ian E Smith; William F Symmans; Baljit Singh; Eric P Winer
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):814-9.
2008: Jer-Yen Yang; Cong S Zong; Weiya Xia; Hirohito Yamaguchi; Qingqing Ding; Xiaoming Xie; Jing-Yu Lang; Chien-Chen Lai; Chun-Ju Chang; Huang Wei-Chien; Hsin Huang; Hsu-Ping Kuo; Dung-Fang Lee; Long-Yuan Li; Huang-Chun Lien; Xiaoyun Cheng; King-Jen Chang; Chwan-Deng Hsiao; Fuu-Jen Tsai; Chang-Hai Tsai; Aysegul A Sahin; William J Muller; Gordon B Mills; Dihua Yu; Gabriel N Hortobagyi; Mien-Chie Hung
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.
Nature cell biology 2008;10(2):138-48.
2008: Fabrice Andre; Rita Nahta; R Conforti; Thomas Boulet; M Aziz; Linda X H Yuan; Franck Meslin; Marc Spielmann; Gorana Tomasic; Lajos Pusztai; Gabriel N Hortobagyi; Stefan Michiels; Suzette Delaloge; Francisco J Esteva
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):315-20.
2008: Jacqueline S Jeruss; Elizabeth A Mittendorf; Susan L Tucker; Ana M Gonzalez-Angulo; Thomas Buchholz; Aysegul A Sahin; Janice N Cormier; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):246-52.
2008: Attila Tordai; Jing Wang; Fabrice Andre; Cornelia Liedtke; Kai Yan; C Sotiriou; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Evaluation of biological pathways involved in chemotherapy response in breast cancer.
Breast cancer research : BCR 2008;10(2):R37.
2008: Cornelia Liedtke; Luca Cardone; Attila Tordai; Kai Yan; Henry L Gomez; Luis J Barajas Figureoa; Rebekah E Hubbard; Vicente Valero; Eduardo A Souchon; W Fraser Symmans; Gabriel N Hortobagyi; Alberto Bardelli; Lajos Pusztai
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
Breast cancer research : BCR 2008;10(2):R27.
2008: Ozlem Er; Debra K Frye; Shu-Wan C Kau; Kristine Broglio; Vicente Valero; Gabriel N Hortobagyi; Banu Arun
Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Cancer journal (Sudbury, Mass.) 2008;14(1):62-8.
2007: Kadri Altundag; Melissa L Bondy; Nadeem Q Mirza; Shu-Wan Kau; Kristine Broglio; Gabriel N Hortobagyi; Edgardo Rivera
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Cancer 2007;110(12):2640-7.
2007: Garth Beinart; Ana M Gonzalez-Angulo; Kristine Broglio; Jaime A Mejia, M.D.; Anthony Ruggeri; Eric Mininberg; Gabriel N Hortobagyi; Vicente Valero
Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
Clinical breast cancer 2007;7(11):867-74.
2007: Flavia Morales-Vásquez; Ana M Gonzalez-Angulo; Kristine Broglio; Horacio N Lopez-Basave; Dolores Gallardo; Gabriel N Hortobagyi; Jaime de la Garza
Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
The breast journal 2007;13(6):551-6.
2007: Emer O Hanrahan; Ana M Gonzalez-Angulo; Sharon H Giordano; Roman Rouzier; Kristine Broglio; Gabriel N Hortobagyi; Vicente Valero
Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4952-60.
2007: Kristen J Vogel; Deann P Atchley; Julie Erlichman; Kristine Broglio; Kaylene J Ready; Vicente Valero; Christopher I Amos; Gabriel N Hortobagyi; Karen H Lu; Banu Arun
BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4635-41.
2007: Hui Wen Lo; Sheng-Chieh Hsu; Weiya Xia; Xinyu Cao; Jin-Yuan Shih; Yongkun Wei; James L Abbruzzese; Gabriel N Hortobagyi; Mien-Chie Hung
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
Cancer research 2007;67(19):9066-76.
2007: Chien-Hsing Lu; Shannon L Wyszomierski; Ling-Ming Tseng; Meng-hong Sun; Keng-Hsueh Lan; Christopher L Neal; Gordon B Mills; Gabriel N Hortobagyi; Francisco J Esteva; Dihua Yu
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5883-8.
2007: Abenaa Brewster; Kim-Anh Do; Patricia A Thompson; Karin M E Hahn; Aysegul A Sahin; Yumei Cao; Maureen M Stewart; James L Murray; Gabriel N Hortobagyi; Melissa L Bondy
Relationship between epidemiologic risk factors and breast cancer recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4438-44.
2007: W Fraser Symmans; Florentia Peintinger; Christos Hatzis; Radhika Rajan; Henry M Kuerer; Vicente Valero; Lina Assad; Anna Poniecka; Bryan T. J. Hennessy; Marjorie Green; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi; Lajos Pusztai
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4414-22.
2007: Massimo Cristofanilli; Vicente Valero; Aman U Buzdar; Shu-Wan Kau; Kristine Broglio; Ana M Gonzalez-Angulo; Nour Sneige; Rabiul Islam; Naoto T Ueno; Thomas Buchholz; S Eva Singletary; Gabriel N Hortobagyi
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
Cancer 2007;110(7):1436-44.
2007: Jennifer K Litton; Yesim Eralp; Ana M Gonzalez-Angulo; Kristine Broglio; Anne R Uyei; Gabriel N Hortobagyi; Banu Arun
Multifocal breast cancer in women < or =35 years old.
Cancer 2007;110(7):1445-50.
2007: Shaheenah Dawood; Ana M Gonzalez-Angulo; Florentia Peintinger; Kristine Broglio; W Fraser Symmans; Shu-Wan Kau; Rabiul Islam; Gabriel N Hortobagyi; Aman U Buzdar
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.
Cancer 2007;110(6):1195-200.
2007: Mary C Pinder; Zhigang Duan; James S Goodwin; Gabriel N Hortobagyi; Sharon H Giordano
Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3808-15.
2007: Debra A Patt; Zhigang Duan; Shenying Fang; Gabriel N Hortobagyi; Sharon H Giordano
Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3871-6.
2007: Banu Arun; Vicente Valero; Catherine Logan; Kristine Broglio; Edgardo Rivera; Abenaa Brewster; Guosheng Yin; Marjorie Green; Henry M Kuerer; Yun Gong; Doris Browne; Gabriel N Hortobagyi; Nour Sneige
Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4943-8.
2007: Dung-Fang Lee; Hsu-Ping Kuo; Chun-Te Chen; Jung-Mao Hsu; Chao-Kai Chou; Yongkun Wei; Hui-Lung Sun; Long-Yuan Li; Bo Ping; Huang Wei-Chien; Xianghuo He; Jen-Yu Hung; Chien-Chen Lai; Qingqing Ding; Jen-Liang Su; Jer-Yen Yang; Aysegul A Sahin; Gabriel N Hortobagyi; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.
Cell 2007;130(3):440-55.
2007: Edith A Perez; Guillermo Lerzo; Xavier Pivot; Eva Thomas; Linda Vahdat; Linda Bosserman; Patrice Viens; Can Cai; Brian Mullaney; Ronald Peck; Gabriel N Hortobagyi
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3407-14.
2007: Fumiyuki Yamasaki; Dongwei Zhang; Chandra Bartholomeusz; Tamotsu Sudo; Gabriel N Hortobagyi; Kaoru Kurisu; Naoto T Ueno
Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity.
Molecular cancer therapeutics 2007;6(8):2168-77.
2007: Florentia Peintinger; Keith Anderson; Chafika Mazouni; Henry M Kuerer; Christos Hatzis; Feng Lin; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4078-82.
2007: Sean E McGuire; Ana M Gonzalez-Angulo; Eugene H Huang; Susan L Tucker; Shu-Wan Kau; Tse-Kuan Yu; Eric A Strom; Julia L Oh; Wendy A Woodward; Welela Tereffe; Kelly K Hunt; Henry M Kuerer; Aysegul A Sahin; Gabriel N Hortobagyi; Thomas Buchholz
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.
International journal of radiation oncology, biology, physics 2007;68(4):1004-9.
2007: Chafika Mazouni; Florentia Peintinger; Shu Wan-Kau; Fabrice Andre; Ana M Gonzalez-Angulo; W Fraser Symmans; Funda Meric-Bernstam; Vicente Valero; Gabriel N Hortobagyi; Lajos Pusztai
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2650-5.
2007: Taimur Sher; Bryan T. J. Hennessy; Vicente Valero; Kristine Broglio; Wendy A Woodward; Jonathan Trent; Kelly K Hunt; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Primary angiosarcomas of the breast.
Cancer 2007;110(1):173-8.
2007: Fumiyuki Yamasaki; Mary J Johansen; Dongwei Zhang; Savitri Krishnamurthy; Edward Felix; Chandra Bartholomeusz; Richard J Aguilar; Kaoru Kurisu; Gordon B Mills; Gabriel N Hortobagyi; Naoto T Ueno
Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
Cancer research 2007;67(12):5779-88.
2007: Luis H Camacho; Razelle Kurzrock; Alex Cheung; Diane F Barber; Sanjay Gupta; David C Madoff; Michael J Wallace; E Edmund Kim; Steven A Curley; Gabriel N Hortobagyi; Giora Mavligit
Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.
Cancer 2007;109(11):2190-6.
2007: Neslihan Cabioglu; Y Gong; Rabiul Islam; Kristine Broglio; Nour Sneige; Aysegul Sahin; Ana M Gonzalez-Angulo; Paolo Morandi; C Bucana; Gabriel N Hortobagyi; Massimo Cristofanilli
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(6):1021-9.
2007: Garth A Beinart; Ana M Gonzalez-Angulo; Kristine Broglio; Debra Frye; Ronald Walters; Frankie A Holmes; Shivaji Gunale; Daniel J Booser; Julian Rosenthal; Kapil Dhingra; James A Young; Gabriel N Hortobagyi
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Cancer chemotherapy and pharmacology 2007;60(1):61-7.
2007: Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2831-5.
2007: Barbara S Craft; Gabriel N Hortobagyi; Stacy L Moulder
Adjuvant biologic therapy for breast cancer.
Cancer journal (Sudbury, Mass.) 2007;13(3):156-61.
2007: Chafika Mazouni; Shu-Wan Kau; Debra Frye; Fabrice Andre; Henry M Kuerer; Thomas Buchholz; W Fraser Symmans; Keith Anderson; Kenneth R Hess; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Aman U Buzdar; Lajos Pusztai
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):874-80.
2007: Gabriel N Hortobagyi
A shortage of oncologists? The American Society of Clinical Oncology workforce study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1468-9.
2007: Fabrice Andre; Christos Hatzis; Keith Anderson; Christos Sotiriou; Chafika Mazouni; Jaime A Mejia, M.D.; Bailiang Wang; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2061-7.
2007: Sharon H Giordano; Gabriel N Hortobagyi
Local recurrence or cardiovascular disease: pay now or later.
Journal of the National Cancer Institute 2007;99(5):340-1.
2007: Yun Gong; Kai Yan; Feng Lin; Keith Anderson; Christos Sotiriou; Fabrice Andre; Frankie A Holmes; Vicente Valero; Daniel J Booser; John Pippen; Svetislava Vukelja; Henry Gomez; Jaime A Mejia, M.D.; Luis J Barajas; Kenneth R Hess; Nour Sneige; Gabriel N Hortobagyi; Lajos Pusztai; W Fraser Symmans
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
The lancet oncology 2007;8(3):203-11.
2007: Massimo Cristofanilli; Kristine Broglio; Valentina Guarneri; Summer Jackson; Herbert A Fritsche; Rabiul Islam; Shaheenah Dawood; James M Reuben; Shu-Wan Kau; Juanita M Lara; Savitri Krishnamurthy; Naoto T Ueno; Gabriel N Hortobagyi; Vicente Valero
Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden.
Clinical breast cancer 2007;7(6):471-9.
2007: Eugene H Huang; Eric A Strom; Vicente Valero; Bruno D Fornage; George H Perkins; Julia L Oh; Tse-Kuan Yu; Welela Tereffe; Wendy A Woodward; Kelly K Hunt; Funda Meric-Bernstam; Aysegul A Sahin; Isabelle Bedrosian; Gabriel N Hortobagyi; Thomas Buchholz
Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.
International journal of radiation oncology, biology, physics 2007;67(2):490-6.
2007: Chafika Mazouni; Angeline Hall; Kristine Broglio; Herbert A Fritsche; Fabrice Andre; Francisco J Esteva; Gabriel N Hortobagyi; Aman U Buzdar; Lajos Pusztai; Massimo Cristofanilli
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
Cancer 2007;109(3):496-501.
2007: Francisco J Esteva; Jing Wang; Feng Lin; Jaime A Mejia, M.D.; Kai Yan; Kadri Altundag; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
Breast cancer research : BCR 2007;9(6):R87.
2007: Ana M Gonzalez-Angulo; Flavia Morales-Vasquez; Gabriel N Hortobagyi
Overview of resistance to systemic therapy in patients with breast cancer.
Advances in experimental medicine and biology 2007;608():1-22.
2007: Aman U Buzdar; Vicente Valero; Nuhad K Ibrahim; Deborah Francis; Kristine Broglio; Richard L Theriault; Lajos Pusztai; Marjorie C Green; S Eva Singletary; Kelly K Hunt; Aysegul A Sahin; Francisco J Esteva; W Fraser Symmans; Michael S Ewer; Thomas Buchholz; Gabriel N Hortobagyi
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):228-33.
2006: Ana M Gonzalez-Angulo; Aysegul Sahin; Savitri Krishnamurthy; Ying Yang; Shu-Wan Kau; Gabriel N Hortobagyi; Massimo Cristofanilli
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma.
Clinical breast cancer 2006;7(5):396-400.
2006: Wendy A Woodward; Eugene H Huang; Marsha D McNeese; George H Perkins; Susan L Tucker; Eric A Strom; Lavinia P Middleton; Karin Hahn; Gabriel N Hortobagyi; Thomas Buchholz
African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.
Cancer 2006;107(11):2662-8.
2006: Fabrice Andre; Chafika Mazouni; Gabriel N Hortobagyi; Lajos Pusztai
DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design.
Biochimica et biophysica acta 2006;1766(2):197-204.
2006: Ana M Gonzalez-Angulo; Valentina Guarneri; Yun Gong; Massimo Cristofanilli; Flavia Morales-Vasquez; Nour Sneige; Gabriel N Hortobagyi; Francisco J Esteva
Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer.
Clinical breast cancer 2006;7(4):326-30.
2006: Roman Rouzier; Lajos Pusztai; Jean-Rémi Garbay; Suzette Delaloge; Kelly K Hunt; Gabriel N Hortobagyi; Donald Berry; Henry M Kuerer
Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
Cancer 2006;107(7):1459-66.
2006: Eugene H Huang; Eric A Strom; George H Perkins; Julia L Oh; Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Aysegul A Sahin; Gabriel N Hortobagyi; Thomas Buchholz
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
International journal of radiation oncology, biology, physics 2006;66(2):352-7.
2006: Edgardo Rivera; Christina Meyers; Morris Groves; Vicente Valero; Deborah Francis; Banu Arun; Kristine Broglio; Guosheng Yin; Gabriel N Hortobagyi; Thomas Buchholz
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
Cancer 2006;107(6):1348-54.
2006: Karin M E Hahn; Peter H Johnson; Nancy Gordon; Henry M Kuerer; Lavinia P Middleton; Mildred Ramirez; Wei Yang; George Perkins; Gabriel N Hortobagyi; Richard L Theriault
Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Cancer 2006;107(6):1219-26.
2006: Kenneth R Hess; Keith Anderson; W Fraser Symmans; Vicente Valero; Nuhad Ibrahim; Jaime A Mejia, M.D.; Daniel J Booser; Richard L Theriault; Aman U Buzdar; Peter J Dempsey; Roman Rouzier; Nour Sneige; Jeffrey S Ross; Tatiana Vidaurre; Henry L Gómez; Gabriel N Hortobagyi; Lajos Pusztai
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4236-44.
2006: Valentina Guarneri; Daniel J Lenihan; Vicente Valero; Jean-Bernard Durand; Kristine Broglio; Kenneth R Hess; Laura Boehnke Michaud; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Francisco J Esteva
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4107-15.
2006: Massimo Cristofanilli; Savitri Krishnamurthy; Laura Guerra; Kristine Broglio; Banu Arun; Daniel J Booser; Kerstin B Menander; Jill van Wart Hood; Vicente Valero; Gabriel N Hortobagyi
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach.
Cancer 2006;107(5):935-44.
2006: Zhenming Yu; Weiya Xia; Hong-Ying Wang; Shao-Chun Wang; Yong Pan; Ka Yin Kwong; Gabriel N Hortobagyi; Mien-Chie Hung
Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1.
Molecular carcinogenesis 2006;45(9):667-75.
2006: Mauricio Z Baptista; Victor G Prieto; Susan Chon; Gabriel N Hortobagyi; Francisco J Esteva
Tamoxifen-related vasculitis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3504-5.
2006: Sharon H Giordano; Gabriel N Hortobagyi
Leuprolide acetate plus aromatase inhibition for male breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):e42-3.
2006: Thomas Buchholz; Eric A Strom; Mary Jane Oswald; George H Perkins; Julia Oh; Delora Domain; Tse-Kuan Yu; Wendy A Woodward; Welela Tereffe; S Eva Singletary; Eva Thomas; Aman U Buzdar; Gabriel N Hortobagyi; Marsha D McNeese
Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
International journal of radiation oncology, biology, physics 2006;65(4):1155-60.
2006: C-P Day; Kung-Ming Rau; L Qiu; C-W Liu; Hsu-Ping Kuo; Xiaoming Xie; G Lopez-Berestein; Gabriel N Hortobagyi; Mien-Chie Hung
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
Cancer gene therapy 2006;13(7):706-19.
2006: Wendy A Woodward; vincent vinh-hung; Naoto T Ueno; Yee Chung Cheng; Melanie Royce; Patricia Tai; Georges Vlastos; Anne Marie Wallace; Gabriel N Hortobagyi; Yago Nieto
Prognostic value of nodal ratios in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2910-6.
2006: Sharon H Giordano; Zhigang Duan; Yong-Fang Kuo; Gabriel N Hortobagyi; James S Goodwin
Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2750-6.
2006: Wendy A Woodward; Sharon H Giordano; Zhigang Duan; Gabriel N Hortobagyi; Thomas Buchholz
Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
Cancer 2006;106(12):2556-62.
2006: Emer O Hanrahan; Kristine Broglio; Debra Frye; Aman U Buzdar; Richard L Theriault; Vicente Valero; Daniel J Booser; S Eva Singletary; Eric A Strom; James L Gajewski; Richard E Champlin; Gabriel N Hortobagyi
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Cancer 2006;106(11):2327-36.
2006: Gildy V Babiera; Roshni Rao; Lei Feng; Funda Meric-Bernstam; Henry M Kuerer; S Eva Singletary; Kelly K Hunt; Merrick I Ross; Karin Gwyn; Barry W Feig; Frederick C Ames; Gabriel N Hortobagyi
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
Annals of surgical oncology 2006;13(6):776-82.
2006: F J Esteva; Gabriel N Hortobagyi
Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Breast (Edinburgh, Scotland) 2006;15(3):301-12.
2006: Rita Nahta; Dihua Yu; Mien-Chie Hung; Gabriel N Hortobagyi; Francisco J Esteva
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer.
Nature clinical practice. Oncology 2006;3(5):269-80.
2006: Emer O Hanrahan; Vicente Valero; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):2113-22.
2006: C H Yang; Ana M Gonzalez-Angulo; James M Reuben; Daniel J Booser; Lajos Pusztai; Savitri Krishnamurthy; Dixie Esseltine; James Stec; Kristine Broglio; Rabiul Islam; Gabriel N Hortobagyi; Massimo Cristofanilli
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):813-7.
2006: Manfred Kaufmann; Gabriel N Hortobagyi; Aron Goldhirsch; Suzy Scholl; Andreas Makris; Pinuccia Valagussa; Jens-Uwe Blohmer; Wolfgang Eiermann; Raimund Jackesz; Walter Jonat; Annette Lebeau; Sibylle Loibl; William Miller; Sigfried Seeber; Vladimir Semiglazov; Roy Smith; Rainer Souchon; Vered Stearns; Michael Untch; Gunter von Minckwitz
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2006: Nancy E Avis; Kevin W Smith; Carol L Link; Gabriel N Hortobagyi; Edgardo Rivera
Factors associated with participation in breast cancer treatment clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1860-7.
2006: Bryan T. J. Hennessy; Sharon H Giordano; Kristine Broglio; Zhigang Duan; Jonathan Trent; Thomas Buchholz; G Babiera; Gabriel N Hortobagyi; Vicente Valero
Biphasic metaplastic sarcomatoid carcinoma of the breast.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):605-13.
2006: Keith Anderson; Kenneth R Hess; Mini Kapoor; Stephen Tirrell; Jean Courtemanche; Bailiang Wang; Yun Wu; Yun Gong; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Reproducibility of gene expression signature-based predictions in replicate experiments.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1721-7.
2006: Sharon H Giordano; Zhigang Duan; Yong-Fang Kuo; Gabriel N Hortobagyi; Jean Freeman; James S Goodwin
Impact of a scientific presentation on community treatment patterns for primary breast cancer.
Journal of the National Cancer Institute 2006;98(6):382-8.
2006: Valentina Guarneri; Kristine Broglio; Shu-Wan Kau; Massimo Cristofanilli; Aman U Buzdar; Vicente Valero; Thomas Buchholz; Funda Meric; Lavinia P Middleton; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1037-44.
2006: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Massimo Cristofanilli; Shu-Wan Kau; Kristine Broglio; Bruno D Fornage; S Eva Singletary; Aysegul Sahin; Aman U Buzdar; Vicente Valero
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy.
Cancer 2006;106(5):1000-6.
2006: Ian S Fentiman; Alain Fourquet; Gabriel N Hortobagyi
Male breast cancer.
Lancet 2006;367(9510):595-604.
2006: Alberto Ocaña; Gabriel N Hortobagyi; Francisco J Esteva
Concomitant versus sequential chemotherapy in the treatment of early-stage and metastatic breast cancer.
Clinical breast cancer 2006;6(6):495-504.
2006: I-Fen Chen; Fu Ou-Yang; Jen-Yu Hung; Jaw-Ching Liu; Hongying Wang; Shao-Chun Wang; Ming-Feng Hou; Gabriel N Hortobagyi; Mien-Chie Hung
AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model.
Molecular cancer therapeutics 2006;5(1):1-7.
2006: Fu Ou-Yang; Keng-Li Lan; Chun-Te Chen; Jaw-Ching Liu; Chu-Li Weng; Chao-Kai Chou; Xiaoming Xie; Jen-Yu Hung; Yongkun Wei; Gabriel N Hortobagyi; Mien-Chie Hung
Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.
Cancer research 2006;66(1):378-84.
2005: Bryan T. J. Hennessy; Gabriel N Hortobagyi; Roman Rouzier; Henry M Kuerer; Nour Sneige; Aman U Buzdar; Shu-Wan Kau; Bruno D Fornage; Aysegul Sahin; Kristine Broglio; S Eva Singletary; Vicente Valero
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9304-11.
2005: Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Pharmacogenomics and clinical biomarkers in drug discovery and development.
American journal of clinical pathology 2005;124 Suppl():S29-41.
2005: Kathy S Albain; Jaime De la Garza-Salazar; Tadeusz Pienkowski; Matti Aapro; Jonas Bergh; Maira Caleffi; Robert Coleman; Wolfgang Eiermann; Fikri Icli; Mark D Pegram; Martine Piccart; Raymond Snyder; Masakazu Toi; Gabriel N Hortobagyi
Reducing the global breast cancer burden: the importance of patterns of care research.
Clinical breast cancer 2005;6(5):412-20.
2005: Gabriel N Hortobagyi; Jaime De la Garza-Salazar; Kathleen Pritchard; Dino Amadori; Renate Haidinger; Clifford Hudis; Hussein M Khaled; Mei-Ching Liu; Miguel Martin; Moise Namer; Joyce A O'Shaughnessy; Zhen Zhou Shen; Kathy S Albain
The global breast cancer burden: variations in epidemiology and survival.
Clinical breast cancer 2005;6(5):391-401.
2005: Bryan T. J. Hennessy; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi
Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics.
Nature clinical practice. Oncology 2005;2(12):598-9.
2005: W Fraser Symmans; Derek J Fiterman; S K Anderson; Mark Ayers; Roman Rouzier; Valerie Dunmire; James Stec; Vicente Valero; Nour Sneige; Constance T Albarracin; Yun Wu; Jeffrey S Ross; Peter Wagner; Richard L Theriault; Banu Arun; Henry M Kuerer; Kenneth R Hess; Wei Zhang; Gabriel N Hortobagyi; Lajos Pusztai
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.
Endocrine-related cancer 2005;12(4):1059-69.
2005: Thomas Buchholz; Amit K Garg; Nitin Chakravarti; Bharat B Aggarwal; Francisco J Esteva; Henry M Kuerer; S Eva Singletary; Gabriel N Hortobagyi; Lajos Pusztai; Massimo Cristofanilli; Aysegul A Sahin
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8398-402.
2005: Sharon H Giordano; George H Perkins; Kristine Broglio; Sherry G Garcia; Lavinia P Middleton; Aman U Buzdar; Gabriel N Hortobagyi
Adjuvant systemic therapy for male breast carcinoma.
Cancer 2005;104(11):2359-64.
2005: Roman Rouzier; Lajos Pusztai; Suzette Delaloge; Ana M Gonzalez-Angulo; Fabrice Andre; Kenneth R Hess; Aman U Buzdar; Jean-Rémi Garbay; Marc Spielmann; Marie-Christine Mathieu; W Fraser Symmans; Peter Wagner; david atallah; Vicente Valero; Donald A Berry; Gabriel N Hortobagyi
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8331-9.
2005: Bryan T. J. Hennessy; Savitri Krishnamurthy; Sharon H Giordano; Thomas Buchholz; Shu-Wan Kau; Zhigang Duan; Vicente Valero; Gabriel N Hortobagyi
Squamous cell carcinoma of the breast.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7827-35.
2005: Gabriel N Hortobagyi
Trastuzumab in the treatment of breast cancer.
The New England journal of medicine 2005;353(16):1734-6.
2005: Debra A Patt; James S Goodwin; Yong-Fang Kuo; Jean L Freeman; Dong D Zhang; Thomas Buchholz; Gabriel N Hortobagyi; Sharon H Giordano
Cardiac morbidity of adjuvant radiotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7475-82.
2005: Luca Gianni; Milvia Zambetti; Kim Clark; Joffre Baker; Maureen Cronin; Jenny Wu; Gabriella Mariani; Jaime Rodriguez; Marialuisa Carcangiu; Drew Watson; Pinuccia Valagussa; Roman Rouzier; W Fraser Symmans; Jeffrey S Ross; Gabriel N Hortobagyi; Lajos Pusztai; Steven Shak
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(29):7265-77.
2005: Naomi R Schechter; Eric A Strom; George H Perkins; Isadora Arzu; Marsha D McNeese; Howard N Langstein; Steven J Kronowitz; Funda Meric-Bernstam; Gildy V Babiera; Kelly K Hunt; Gabriel N Hortobagyi; Thomas Buchholz
Immediate breast reconstruction can impact postmastectomy irradiation.
American journal of clinical oncology 2005;28(5):485-94.
2005: Ana M Gonzalez-Angulo; Sean E McGuire; Thomas Buchholz; Susan L Tucker; Henry M Kuerer; Roman Rouzier; Shu-Wan Kau; Eugene H Huang; Paolo Morandi; Alberto Ocana; Massimo Cristofanilli; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7098-104.
2005: Emer O Hanrahan; Kristine Broglio; Aman U Buzdar; Richard L Theriault; Vicente Valero; Massimo Cristofanilli; Guosheng Yin; Shu-Wan Kau; Gabriel N Hortobagyi; Edgardo Rivera
Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Cancer 2005;104(6):1158-71.
2005: Nuhad K Ibrahim; Barry Samuels; Ray Page; Dinesh Doval; Kirtikumar M Patel; S C Rao; M Krishnan Nair; Paul Bhar; Neil Desai; Gabriel N Hortobagyi
Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6019-26.
2005: Marjorie C Green; Aman U Buzdar; Terry Smith; Nuhad K Ibrahim; Vicente Valero; Marguerite F Rosales; Massimo Cristofanilli; Daniel J Booser; Lajos Pusztai; Edgardo Rivera; Richard L Theriault; Cynthia Carter; Debra Frye; Kelly K Hunt; W Fraser Symmans; Eric A Strom; Aysegul A Sahin; William Sikov; Gabriel N Hortobagyi
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5983-92.
2005: Kelly K Hunt; Thomas Buchholz; Gabriel N Hortobagyi
Now and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy.
Annals of surgical oncology 2005;12(9):683-5.
2005: Neslihan Cabioglu; M Sertac Yazici; Banu Arun; Kristine Broglio; Gabriel N Hortobagyi; Janet E Price; Aysegul Sahin
CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5686-93.
2005: Roman Rouzier; Charles M Perou; W Fraser Symmans; Nuhad Ibrahim; Massimo Cristofanilli; Keith Anderson; Kenneth R Hess; James Stec; Mark Ayers; Peter Wagner; Paolo Morandi; Chang Fan; Islam Rabiul; Jeffrey S Ross; Gabriel N Hortobagyi; Lajos Pusztai
Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5678-85.
2005: Lajos Pusztai; Peter Wagner; Nuhad Ibrahim; Edgardo Rivera; Richard Theriault; Daniel J Booser; Fraser W Symmans; Franklin Wong; George R Blumenschein; Donald R Fleming; Roman Rouzier; Graeme Boniface; Gabriel N Hortobagyi
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.
Cancer 2005;104(4):682-91.
2005: Thomas Buchholz; Xiaoyu Tu; K. Kian Ang; Francisco J Esteva; Henry M Kuerer; Lajos Pusztai; Massimo Cristofanilli; S Eva Singletary; Gabriel N Hortobagyi; Aysegul A Sahin
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
Cancer 2005;104(4):676-81.
2005: James Stec; Jing Wang; Kevin R Coombes; Mark Ayers; Sebastian Hoersch; David L Gold; Jeffrey S Ross; Kenneth R Hess; Stephen Tirrell; Gerald P Linette; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips.
The Journal of molecular diagnostics : JMD 2005;7(3):357-67.
2005: Bryan T. J. Hennessy; A M Gauthier; L B Michaud; Gabriel N Hortobagyi; Vicente Valero
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1289-96.
2005: Alberto Montero; Roman Rouzier; Ana Lluch; Richard L Theriault; Aman U Buzdar; Suzette Delaloge; Begoñia Bermejo; Monique Le; Shu-Wan Kau; Ariane Dunant; Rodrigo Arriagada; Marc Spielmann; Javier Garcia-Conde; Aysegul A Sahin; S Eva Singletary; Gabriel N Hortobagyi; Vicente Valero
The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.
Cancer 2005;104(2):229-35.
2005: Ana M Gonzalez-Angulo; Kristine Broglio; Shu-Wan Kau; Yesim Eralp; Julie Erlichman; Vicente Valero; Richard Theriault; Daniel J Booser; Aman U Buzdar; Gabriel N Hortobagyi; Banu Arun
Women age < or = 35 years with primary breast carcinoma: disease features at presentation.
Cancer 2005;103(12):2466-72.
2005: Roman Rouzier; Radhika Rajan; Peter Wagner; Kenneth R Hess; David L Gold; James Stec; Mark Ayers; Jeffrey S Ross; Peter Zhang; Thomas Buchholz; Henry M Kuerer; Marjorie Green; Banu Arun; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(23):8315-20.
2005: Eugene H Huang; Susan L Tucker; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Gabriel N Hortobagyi; Aman U Buzdar; Vicente Valero; George H Perkins; Naomi R Schechter; Kelly K Hunt; Aysegul A Sahin; Thomas Buchholz
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
International journal of radiation oncology, biology, physics 2005;62(2):351-7.
2005: Aman U Buzdar; Nuhad K Ibrahim; Deborah Francis; Daniel J Booser; Eva S Thomas; Richard L Theriault; Lajos Pusztai; Marjorie C Green; Banu Arun; Sharon H Giordano; Massimo Cristofanilli; Debra Frye; Terry L Smith; Kelly K Hunt; S Eva Singletary; Aysegul A Sahin; Michael S Ewer; Thomas Buchholz; Donald Berry; Gabriel N Hortobagyi
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3676-85.
2005: Gabriel N Hortobagyi
Progress in the management of bone metastases: one continent at a time?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3299-301.
2005: Francisco J Esteva; Aysegul A Sahin; Massimo Cristofanilli; Kevin R Coombes; Sang-Joon Lee; Joffre Baker; Maureen Cronin; Michael Walker; Drew Watson; Steven Shak; Gabriel N Hortobagyi
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3315-9.
2005: Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas Buchholz; Gabriel N Hortobagyi; James S Goodwin
Risk of cardiac death after adjuvant radiotherapy for breast cancer.
Journal of the National Cancer Institute 2005;97(6):419-24.
2005: Massimo Cristofanilli; Yuko Yamamura; Shu-Wan Kau; Therese B Bevers; Sara Strom; Modesto Patangan; Limin Hsu; Savitri Krishnamurthy; Richard L Theriault; Gabriel N Hortobagyi
Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma.
Cancer 2005;103(6):1122-8.
2005: Massimo Cristofanilli; Daniel F Hayes; G Thomas Budd; Matthew J Ellis; Alison T Stopeck; James M Reuben; Gerald V Doyle; Jeri Matera; W Jeffrey Allard; M Craig Miller; Herbert A Fritsche; Gabriel N Hortobagyi; Leon W M M Terstappen
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1420-30.
2005: Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Howard D Thames; Elesyia D Outlaw; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Frederick C Ames; Barry W Feig; Aysegul A Sahin; George H Perkins; Gildy V Babiera; Gabriel N Hortobagyi; Thomas Buchholz
Breast conservation after neoadjuvant chemotherapy.
Cancer 2005;103(4):689-95.
2005: Sharon H Giordano; Gabriel N Hortobagyi; Shu-Wan Kau; Richard L Theriault; Melissa L Bondy
Breast cancer treatment guidelines in older women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):783-91.
2005: Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Breast cancer biomarkers.
Advances in clinical chemistry 2005;40():99-125.
2005: Gabriel N Hortobagyi
Moving into the future: treatment of bone metastases and beyond.
Cancer treatment reviews 2005;31 Suppl 3():9-18.
2005: Lajos Pusztai; Fraser W Symmans; Gabriel N Hortobagyi
Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer.
Breast cancer (Tokyo, Japan) 2005;12(2):73-85.
2005: Massimo Cristofanilli; Ana M Gonzalez-Angulo; Nour Sneige; Shu-Wan Kau; Kristine Broglio; Richard L Theriault; Vicente Valero; Aman U Buzdar; Henry M Kuerer; Thomas A Buccholz; Gabriel N Hortobagyi
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):41-8.
2004: Robert C Bast; Gabriel N Hortobagyi
Individualized care for patients with cancer - a work in progress.
The New England journal of medicine 2004;351(27):2865-7.
2004: Eugene H Huang; Susan L Tucker; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Aman U Buzdar; Vicente Valero; George H Perkins; Naomi R Schechter; Kelly K Hunt; Aysegul A Sahin; Gabriel N Hortobagyi; Thomas Buchholz
Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4691-9.
2004: Tse-Kuan Yu; Gary J Whitman; Howard D Thames; Aman U Buzdar; Eric A Strom; George H Perkins; Naomi R Schechter; Marsha D McNeese; Shu-Wan Kau; Eva S Thomas; Gabriel N Hortobagyi; Thomas Buchholz
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients.
Journal of the National Cancer Institute 2004;96(22):1676-81.
2004: Yan M Li; Yong Pan; Yongkun Wei; Xiaoyun Cheng; Binhua P Zhou; Ming Tan; Xiaoyan Zhou; Weiya Xia; Gabriel N Hortobagyi; Dihua Yu; Mien-Chie Hung
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.
Cancer cell 2004;6(5):459-69.
2004: Yee Chung Cheng; Gabriela Rondón; Ying Yang; Terry L Smith; James L Gajewski; Michele L Donato; Elizabeth J Shpall; Roy Jones; Gabriel N Hortobagyi; Richard E Champlin; Naoto T Ueno
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(11):794-804.
2004: Ana M Gonzalez-Angulo; Massimo Cristofanilli; Eric A Strom; Aman U Buzdar; Shu-Wan Kau; Kristine Broglio; Terry L Smith; Gabriel N Hortobagyi
Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Cancer 2004;101(8):1760-6.
2004: B Wang; Roman Rouzier; Constance T Albarracin; Aysegul Sahin; Peter Wagner; Y Yang; T L Smith; F Meric-Bernstam; C Marcelo Aldaz; A C Marcelo; Gabriel N Hortobagyi; Lajos Pusztai
Expression of sigma 1 receptor in human breast cancer.
Breast cancer research and treatment 2004;87(3):205-14.
2004: Jeffrey S Ross; David P Schenkein; Robert Pietrusko; Mark Rolfe; Gerald P Linette; James Stec; Nancy Stagliano; Geoffrey S Ginsburg; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Targeted therapies for cancer 2004.
American journal of clinical pathology 2004;122(4):598-609.
2004: Zhiyong Li; Nuhad K Ibrahim; J Kyle Wathen; Michael Wang; Rosario P Mante Menchu; Vicente Valero; Richard Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Colitis in patients with breast carcinoma treated with taxane-based chemotherapy.
Cancer 2004;101(7):1508-13.
2004: Ana M Gonzalez-Angulo; Nour Sneige; Aman U Buzdar; Vicente Valero; Shu-Wan Kau; Kristine Broglio; Yuko Yamamura; Gabriel N Hortobagyi; Massimo Cristofanilli
p53 expression as a prognostic marker in inflammatory breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6215-21.
2004: Roman Rouzier; Gabriel N Hortobagyi
The removal of regional nodes even when "pathologically negative" for long-term survival should be discussed cautiously.
Annals of surgical oncology 2004;11(9):879-80.
2004: Erika Resetkova; Ana M Gonzalez-Angulo; Nour Sneige; Timothy J McDonnell; Aman U Buzdar; Shu-Wan Kau; Yuko Yamamura; James M Reuben; Gabriel N Hortobagyi; Massimo Cristofanilli
Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma.
Cancer 2004;101(5):913-7.
2004: Yoichi Nagata; Keng-Hsueh Lan; Xiaoyan Zhou; Ming Tan; Francisco J Esteva; Aysegul A Sahin; Kristine S Klos; Ping Li; Brett P Monia; Nina T Nguyen; Gabriel N Hortobagyi; Mien-Chie Hung; Dihua Yu
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.
Cancer cell 2004;6(2):117-27.
2004: Thomas Buchholz; Eugene H Huang; Donald Berry; Lajos Pusztai; Eric A Strom; Marsha D McNeese; George H Perkins; Naomi R Schechter; Henry M Kuerer; Aman U Buzdar; Vicente Valero; Kelly K Hunt; Gabriel N Hortobagyi; Aysegul A Sahin
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
International journal of radiation oncology, biology, physics 2004;59(5):1337-42.
2004: Tsuyoshi Hamaoka; John E Madewell; Donald A Podoloff; Gabriel N Hortobagyi; Naoto T Ueno
Bone imaging in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2942-53.
2004: Ana M Gonzalez-Angulo; Savitri Krishnamurthy; Yuko Yamamura; Kristine Broglio; Lajos Pusztai; Aman U Buzdar; Gabriel N Hortobagyi; Francisco J Esteva
Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma.
Cancer 2004;101(2):258-63.
2004: Gordon Schwartz; Gabriel N Hortobagyi; Shahla Masood; Juan P Palazzo; Roland Holland; David Page
Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA.
Human pathology 2004;35(7):781-4.
2004: Sharon H Giordano; Deborah S Cohen; Aman U Buzdar; George Perkins; Gabriel N Hortobagyi
Breast carcinoma in men: a population-based study.
Cancer 2004;101(1):51-7.
2004: Jeffrey S Ross; David P Schenkein; Oscar Kashala; Gerald P Linette; James Stec; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Pharmacogenomics.
Advances in anatomic pathology 2004;11(4):211-20.
2004: Gordon Schwartz; Gabriel N Hortobagyi
Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.
Cancer 2004;100(12):2512-32.
2004: Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Howard D Thames; Mary Jane Oswald; Elesyia D Outlaw; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Frederick C Ames; Barry W Feig; Aysegul A Sahin; George H Perkins; Naomi R Schechter; Gabriel N Hortobagyi; Thomas Buchholz
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2303-12.
2004: Eva Thomas; Frankie A Holmes; Terry L Smith; Aman U Buzdar; Debra Frye; Giuseppe Fraschini; S Eva Singletary; Richard L Theriault; Marsha D McNeese; Frederick C Ames; Ronald Walters; Gabriel N Hortobagyi
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2294-302.
2004: Mark Ayers; W Fraser Symmans; James Stec; Andrew I Damokosh; E Clark; K Hess; M Lecocke; J Metivier; Daniel J Booser; Nuhad Ibrahim; Vicente Valero; Melanie Royce; Banu Arun; G Whitman; J Ross; Nour Sneige; Gabriel N Hortobagyi; Lajos Pusztai
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2284-93.
2004: Gabriel N Hortobagyi
What is the role of high-dose chemotherapy in the era of targeted therapies?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2263-6.
2004: Lajos Pusztai; Betsy Gregory; Keith A Baggerly; Bo Peng; John M Koomen; Henry M Kuerer; Francisco J Esteva; W Fraser Symmans; Peter Wagner; Gabriel N Hortobagyi; Christine Laronga; O John Semmes; George L Wright; Richard R Drake; Antonia Vlahou
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.
Cancer 2004;100(9):1814-22.
2004: Amit K Garg; Eric A Strom; Marsha D McNeese; Aman U Buzdar; Gabriel N Hortobagyi; Henry M Kuerer; George H Perkins; S Eva Singletary; Kelly K Hunt; Asyegul Sahin; Naomi R Schechter; Vicente Valero; Susan L Tucker; Thomas Buchholz
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
International journal of radiation oncology, biology, physics 2004;59(1):138-45.
2004: Radhika Rajan; Anna Poniecka; Terry L Smith; Ying Yang; Deborah Frye; Lajos Pusztai; Derek J Fiterman; Eva Gal-Gombos; Gary J Whitman; Roman Rouzier; Marjorie Green; Henry M Kuerer; Aman U Buzdar; Gabriel N Hortobagyi; W Fraser Symmans
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
Cancer 2004;100(7):1365-73.
2004: Jeffrey S Ross; Jonathan A Fletcher; Kenneth J Bloom; Gerald P Linette; James Stec; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Targeted therapy in breast cancer: the HER-2/neu gene and protein.
Molecular & cellular proteomics : MCP 2004;3(4):379-98.
2004: Edgardo Rivera; Vicente Valero; Deborah Francis; Aviva G Asnis; Larry J Schaaf; Barbara Duncan; Gabriel N Hortobagyi
Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1943-8.
2004: Duen-Hwa Yan; Yong Wen; Li-Kuo Su; Weiya Xia; Shao-Chun Wang; Su Zhang; Lin Gan; Dung-Fang Lee; Bill Spohn; Jennifer A Frey; Gabriel N Hortobagyi; Mien-Chie Hung
A delayed chemically induced tumorigenesis in Brca2 mutant mice.
Oncogene 2004;23(10):1896-901.
2004: Jeffrey S Ross; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; Nick Leschly; W Fraser Symmans; Gabriel N Hortobagyi; Lajos Pusztai
Breast cancer biomarkers and molecular medicine: part II.
Expert review of molecular diagnostics 2004;4(2):169-88.
2004: Marisa A Navo; Julie Phan; Christy Vaughan; J Lynn Palmer; Laura Michaud; Kellie L Jones; Diane C Bodurka; Karen Basen-Engquist; Gabriel N Hortobagyi; John J Kavanagh; Judith A Smith
An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):671-7.
2004: Lajos Pusztai; Tito R Mendoza; James M Reuben; Monica M Martinez; Jie S Willey; Juanita Lara; Abdul Syed; Herbert A Fritsche; Eduardo Bruera; Daniel J Booser; Vicente Valero; Banu Arun; Nuhad Ibrahim; Edgardo Rivera; Melanie Royce; Charles S Cleeland; Gabriel N Hortobagyi
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.
Cytokine 2004;25(3):94-102.
2004: Elise C Kohn; Yiling Lu; Hongwei Wang; Qinghua Yu; Shuangxing Yu; Hassan Hall; Debra L Smith; Funda Meric-Bernstam; Gabriel N Hortobagyi; Gordon B Mills
Molecular therapeutics: promise and challenges.
Seminars in oncology 2004;31(1 Suppl 3):39-53.
2004: Gabriel N Hortobagyi
Opportunities and challenges in the development of targeted therapies.
Seminars in oncology 2004;31(1 Suppl 3):21-7.
2004: Massimo Cristofanilli; Ana M Gonzalez-Angulo; Aman U Buzdar; Shu-Wan Kau; Debra Frye; Gabriel N Hortobagyi
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience.
Clinical breast cancer 2004;4(6):415-9.
2004: Francisco J Esteva; Aysegul A Sahin; Terry L Smith; Ying Yang; Lajos Pusztai; Rita Nahta; Thomas Buchholz; Aman U Buzdar; Gabriel N Hortobagyi; Sarah S Bacus
Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
Cancer 2004;100(3):499-506.
2004: L Johnetta Blakely; Aman U Buzdar; Jose A Lozada; Samer A Shullaih; Emma Hoy; Terry L Smith; Gabriel N Hortobagyi
Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
Cancer 2004;100(3):465-9.
2004: Massimo Cristofanilli; Eva Singletary; Gabriel N Hortobagyi
Inflammatory breast carcinoma: the sphinx of breast cancer research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):381-3; author reply 383.
2004: Marjorie C Green; Francisco J Esteva; Gabriel N Hortobagyi
Neoadjuvant chemotherapy.
Breast disease 2004;21():23-31.
2004: Lajos Pusztai; Savitri Krishnamurti; Jorge Perez Cardona; Nour Sneige; Francisco J Esteva; Marina Volchenok; Patricia Breitenfelder; Shu-Wan Kau; Shin Takayama; Stanislaw Krajewski; John C Reed; Robert C Bast; Gabriel N Hortobagyi
Expression of BAG-1 and BcL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancer.
Cancer investigation 2004;22(2):248-56.
2004: Francisco J Esteva; Gabriel N Hortobagyi
Prognostic molecular markers in early breast cancer.
Breast cancer research : BCR 2004;6(3):109-18.
2004: Sharon H Giordano; Aman U Buzdar; Terry L Smith; Shu-Wan Kau; Ying Yang; Gabriel N Hortobagyi
Is breast cancer survival improving?
Cancer 2004;100(1):44-52.
2003: Jeffrey S Ross; Jonathan A Fletcher; Kenneth J Bloom; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
HER-2/neu testing in breast cancer.
American journal of clinical pathology 2003;120 Suppl():S53-71.
2003: Naoto T Ueno; Yee Chung Cheng; Gabriela Rondón; Nizar M Tannir; James L Gajewski; Daniel Couriel; Chitra Hosing; Marcos J de Lima; Paolo Anderlini; Issa F Khouri; Daniel J Booser; Gabriel N Hortobagyi; Lance C Pagliaro; Eric Jonasch; Sergio Giralt; Richard E Champlin
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Blood 2003;102(10):3829-36.
2003: Amit K Garg; Gabriel N Hortobagyi; Bharat B Aggarwal; Aysegul A Sahin; Thomas Buchholz
Nuclear factor-kappa B as a predictor of treatment response in breast cancer.
Current opinion in oncology 2003;15(6):405-11.
2003: Gabriel N Hortobagyi
Novel approaches to the management of bone metastases.
Seminars in oncology 2003;30(5 Suppl 16):161-6.
2003: Aman U Buzdar; Gabriel N Hortobagyi
Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer.
Cancer treatment reviews 2003;29(5):449-52.
2003: Wendy A Woodward; Eric A Strom; Susan L Tucker; Angela Katz; Marsha D McNeese; George H Perkins; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt; Aysegul Sahin; Funda Meric; Nour Sneige; Thomas Buchholz
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
International journal of radiation oncology, biology, physics 2003;57(2):336-44.
2003: Wendy A Woodward; Eric A Strom; Marsha D McNeese; George H Perkins; Eleysia L Outlaw; Gabriel N Hortobagyi; Aman U Buzdar; Thomas Buchholz
Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.
International journal of radiation oncology, biology, physics 2003;57(2):327-35.
2003: Thomas Buchholz; Kelly K Hunt; Gary J Whitman; Aysegul A Sahin; Gabriel N Hortobagyi
Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.
Cancer 2003;98(6):1150-60.
2003: Lajos Pusztai; Jim Hou Zhen; Banu Arun; Edgardo Rivera; Clark Whitehead; W Joseph Thompson; Kimberly M Nealy; Amy Gibbs; W Fraser Symmans; Francisco J Esteva; Daniel J Booser; James L Murray; Vicente Valero; Terry L Smith; Gabriel N Hortobagyi
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3454-61.
2003: Jeffrey S Ross; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; Nick Leschly; W Fraser Symmans; Gabriel N Hortobagyi; Lajos Pusztai
Breast cancer biomarkers and molecular medicine.
Expert review of molecular diagnostics 2003;3(5):573-85.
2003: Edgardo Rivera; Vicente Valero; Banu Arun; Melanie Royce; Rosnie B Adinin; Karen Hoelzer; Ronald Walters; James L Wade Iii; Lajos Pusztai; Gabriel N Hortobagyi
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3249-54.
2003: Wendy A Woodward; Eric A Strom; Susan L Tucker; Marsha D McNeese; George H Perkins; Naomi R Schechter; S Eva Singletary; Richard L Theriault; Gabriel N Hortobagyi; Kelly K Hunt; Thomas Buchholz
Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3244-8.
2003: Francisco J Esteva; Edgardo Rivera; Massimo Cristofanilli; Vicente Valero; Melanie Royce; Anil Duggal; Philippe Colucci; Robert DeJager; Gabriel N Hortobagyi
A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma.
Cancer 2003;98(5):900-7.
2003: Edgardo Rivera; M Haim Erder; Timothy D Moore; Thomas L Shiftan; Chris A Knight; Moshe Fridman; Carol Brannan; Laurence Danel-Moore; Gabriel N Hortobagyi
Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model.
Cancer 2003;98(2):222-8.
2003: Jonathan Trent; Vicente Valero; Daniel J Booser; Laura Guerra; Nuhad Ibrahim; Zia Rahman; Laurent Vernillet; Shreyaskumar Patel; Cynthia L David; James L Murray; Massimo Cristofanilli; Gabriel N Hortobagyi
A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2426-34.
2003: Lajos Pusztai; Mark Ayers; James Stec; Edward Clark; Kenneth Hess; David N Stivers; Andrew I Damokosh; Nour Sneige; Thomas Buchholz; Francisco J Esteva; Banu Arun; Massimo Cristofanilli; Daniel J Booser; Marguerite Rosales; Vicente Valero; Constantine Adams; Gabriel N Hortobagyi; W Fraser Symmans
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2406-15.
2003: Anees B Chagpar; Funda Meric-Bernstam; Kelly K Hunt; Merrick I Ross; Massimo Cristofanilli; S Eva Singletary; Thomas Buchholz; Frederick C Ames; Sylvie Marcy; Gildy V Babiera; Barry W Feig; Gabriel N Hortobagyi; Henry M Kuerer
Chest wall recurrence after mastectomy does not always portend a dismal outcome.
Annals of surgical oncology 2003;10(6):628-34.
2003: W Fraser Symmans; Mark Ayers; Edwin A Clark; James Stec; Kenneth R Hess; Nour Sneige; Thomas Buchholz; Savitri Krishnamurthy; Nuhad K Ibrahim; Aman U Buzdar; Richard L Theriault; Marguerite F Rosales; Eva S Thomas; Karin Gwyn; Marjorie C Green; Abdul R Syed; Gabriel N Hortobagyi; Lajos Pusztai
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
Cancer 2003;97(12):2960-71.
2003: Gabriel N Hortobagyi; Guido Sauter
Challenges and opportunities for Erlotinib (Tarceva): what does the future hold?
Seminars in oncology 2003;30(3 Suppl 7):47-53.
2003: Rita Nahta; Gabriel N Hortobagyi; Francisco J Esteva
Novel pharmacological approaches in the treatment of breast cancer.
Expert opinion on investigational drugs 2003;12(6):909-21.
2003: Rita Nahta; Gabriel N Hortobagyi; Francisco J Esteva
Signal transduction inhibitors in the treatment of breast cancer.
Current medicinal chemistry. Anti-cancer agents 2003;3(3):201-16.
2003: Fan Zhang; Ying Yang; Terry Smith; Shu-Wan Kau; Judy M McConathy; Francisco J Esteva; Henry M Kuerer; W Fraser Symmans; Aman U Buzdar; Gabriel N Hortobagyi; Lajos Pusztai
Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
Cancer 2003;97(7):1758-65.
2003: Francisco J Esteva; John Glaspy; Said Baidas; Leslie R Laufman; Laura F Hutchins; Maura Dickler; Debu Tripathy; Roger Cohen; Angela DeMichele; Richard C Yocum; C Kent Osborne; Daniel F Hayes; Gabriel N Hortobagyi; Eric Winer; George D Demetri
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):999-1006.
2003: Vicente Valero; Gabriel N Hortobagyi
Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):959-62.
2003: E Thomas; Gabriel N Hortobagyi
New paradigms in adjuvant systemic therapy of breast cancer.
Endocrine-related cancer 2003;10(1):75-89.
2003: Kenneth R Hess; Lajos Pusztai; Aman U Buzdar; Gabriel N Hortobagyi
Estrogen receptors and distinct patterns of breast cancer relapse.
Breast cancer research and treatment 2003;78(1):105-18.
2003: Sharon H Giordano; Gabriel N Hortobagyi
Inflammatory breast cancer: clinical progress and the main problems that must be addressed.
Breast cancer research : BCR 2003;5(6):284-8.
2003: Gabriel N Hortobagyi
Future directions in the endocrine therapy of breast cancer.
Breast cancer research and treatment 2003;80 Suppl 1():S37-9.
2003: Gabriel N Hortobagyi
New approaches to breast cancer therapy.
Breast cancer research and treatment 2003;80 Suppl 1():S1-2; discussion S13-8.
2003: Edgardo Rivera; M Haim Erder; Moshe Fridman; Debra Frye; Gabriel N Hortobagyi
First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study.
Breast cancer research : BCR 2003;5(5):R114-20.
2003: Thomas Buchholz; Darren W Davis; David J McConkey; W Fraser Symmans; Vicente Valero; Anuja Jhingran; Susan L Tucker; Lajos Pusztai; Massimo Cristofanilli; Francisco J Esteva; Gabriel N Hortobagyi; Aysegul A Sahin
Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.
Cancer journal (Sudbury, Mass.) 2003;9(1):33-41.
2002: M Cristofanilli; Gabriel N Hortobagyi
Molecular targets in breast cancer: current status and future directions.
Endocrine-related cancer 2002;9(4):249-66.
2002: Khandan Keyomarsi; Susan L Tucker; Thomas Buchholz; Michael Callister; Ye Ding; Gabriel N Hortobagyi; Isabelle Bedrosian; Christopher Knickerbocker; Wendy Toyofuku; Michael Lowe; Thaddeus W Herliczek; Sarah S Bacus
Cyclin E and survival in patients with breast cancer.
The New England journal of medicine 2002;347(20):1566-75.
2002: Thomas Buchholz; David N Stivers; James Stec; Mark Ayers; Edward Clark; Bolt Andrew; Aysegul A Sahin; W Fraser Symmans; Kenneth R Hess; Henry M Kuerer; Vicente Valero; Gabriel N Hortobagyi; Lajos Pusztai
Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.
Cancer journal (Sudbury, Mass.) 2002;8(6):461-8.
2002: Elvio G Silva; Dinu Mistry; Donghui Li; Henry M Kuerer; E Neely Atkinson; Abel N Lopez; Rhonda Shannon; Gabriel N Hortobagyi
Elevated luteinizing hormone in serum, breast cancer tissue, and normal breast tissue from breast cancer patients.
Breast cancer research and treatment 2002;76(2):125-30.
2002: James L Murray; Michael E Gillogly; Donna Przepiorka; Hannah Brewer; Nuhad K Ibrahim; Daniel J Booser; Gabriel N Hortobagyi; Andrzej P Kudelka; Kenneth H Grabstein; Martin A Cheever; Constantin G Ioannides
Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3407-18.
2002: Sharon H Giordano; Daniel J Booser; James L Murray; Nuhad K Ibrahim; Zia Rahman; Vicente Valero; Richard L Theriault; Marguerite F Rosales; Edgardo Rivera; Debra Frye; Michael S Ewer; Nelson G Ordonez; Aman U Buzdar; Gabriel N Hortobagyi
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3360-8.
2002: Georges Vlastos; Nadeem Q Mirza; Funda Meric; Kelly K Hunt; Attiqa N Mirza; Lisa A Newman; Frederick C Ames; Henry M Kuerer; Merrick I Ross; Barry Feig; Gildy V Babiera; Thomas Buchholz; Gabriel N Hortobagyi; S Eva Singletary
Breast-conservation therapy in early-stage breast cancer patients with a positive family history.
Annals of surgical oncology 2002;9(9):912-9.
2002: Rena Vassilopoulou-Sellin; Deborah S Cohen; Gabriel N Hortobagyi; Mary Jean Klein; Marsha D McNeese; S Eva Singletary; Terry L Smith; Richard L Theriault
Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
Cancer 2002;95(9):1817-26.
2002: Sharon H Giordano; Aman U Buzdar; Gabriel N Hortobagyi
Breast cancer in men.
Annals of internal medicine 2002;137(8):678-87.
2002: Vicente Valero; Aman U Buzdar; Marsha D McNeese; Eva Singletary; Gabriel N Hortobagyi
Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.
Clinical breast cancer 2002;3 Suppl 2():S63-8.
2002: Francisco J Esteva; Aysegul A Sahin; Massimo Cristofanilli; Banu Arun; Gabriel N Hortobagyi
Molecular prognostic factors for breast cancer metastasis and survival.
Seminars in radiation oncology 2002;12(4):319-28.
2002: Yi Ding; Yong Wen; Bill Spohn; Li Wang; Weiya Xia; Ka Yin Kwong; Ruping Shao; Zheng Li; Gabriel N Hortobagyi; Mien-Chie Hung; Duen-Hwa Yan
Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3290-7.
2002: Gabriel N Hortobagyi
The status of breast cancer management: challenges and opportunities.
Breast cancer research and treatment 2002;75 Suppl 1():S61-5; discussion S57-9.
2002: Eugene Huang; Marsha D McNeese; Eric A Strom; George H Perkins; Angela Katz; Gabriel N Hortobagyi; Vicente Valero; Henry M Kuerer; S Eva Singletary; Kelly K Hunt; Aman U Buzdar; Thomas Buchholz
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.
International journal of radiation oncology, biology, physics 2002;53(5):1225-33.
2002: Thomas Buchholz; Angela Katz; Eric A Strom; Marsha D McNeese; George H Perkins; Gabriel N Hortobagyi; Howard D Thames; Henry M Kuerer; S Eva Singletary; Aysegul A Sahin; Kelly K Hunt; Aman U Buzdar; Vicente Valero; Nour Sneige; Susan L Tucker
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
International journal of radiation oncology, biology, physics 2002;53(4):880-8.
2002: Marjorie C Green; Gabriel N Hortobagyi
Adjuvant chemotherapy for breast cancer.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2002;387(3-4):109-116.
2002: Marjorie Green; Gabriel N Hortobagyi
Neoadjuvant chemotherapy for operable breast cancer.
Oncology (Williston Park, N.Y.) 2002;16(7):871-84, 889; discussion 889-90, 892-4, 897-8.
2002: Daniel J Booser; Francisco J Esteva; Edgardo Rivera; Vicente Valero; Laura Guerra; Waldemar Priebe; Gabriel N Hortobagyi
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Cancer chemotherapy and pharmacology 2002;50(1):6-8.
2002: Funda Meric; Thomas Buchholz; Nadeem Q Mirza; Georges Vlastos; Frederick C Ames; Merrick I Ross; Raphael E Pollock; S Eva Singletary; Barry W Feig; Henry M Kuerer; Lisa A Newman; George H Perkins; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi; Kelly K Hunt
Long-term complications associated with breast-conservation surgery and radiotherapy.
Annals of surgical oncology 2002;9(6):543-9.
2002: Jianzhou Wang; Thomas Buchholz; Lavinia P Middleton; D Craig Allred; Susan L Tucker; Henry M Kuerer; Francisco J Esteva; Gabriel N Hortobagyi; Aysegul A Sahin
Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.
Cancer 2002;94(12):3107-14.
2002: Gabriel N Hortobagyi; Mark G Kris
Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.
Seminars in oncology 2002;29(3 Suppl 12):1-3.
2002: Gabriel N Hortobagyi
Novel approaches to the management of bone metastases in patients with breast cancer.
Seminars in oncology 2002;29(3 Suppl 11):134-44.
2002: Massimo Cristofanilli; Chusilp Charnsangavej; Gabriel N Hortobagyi
Angiogenesis modulation in cancer research: novel clinical approaches.
Nature reviews. Drug discovery 2002;1(6):415-26.
2002: Gabriel N Hortobagyi
Integration of docetaxel into adjuvant breast cancer treatment regimens.
Oncology (Williston Park, N.Y.) 2002;16(6 Suppl 6):27-33.
2002: Ashraful Hoque; Nour Sneige; Aysegul A Sahin; David G Menter; James Bacus; Gabriel N Hortobagyi; Scott M Lippman
Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(6):587-90.
2002: Bita Esmaeli; Gabriel N Hortobagyi; Francisco J Esteva; Daniel J Booser; M Amir Ahmadi; Edgardo Rivera; Rebecca Arbuckle; Ebrahim S Delpassand; Laura Guerra; Vicente Valero
Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
Ophthalmology 2002;109(6):1188-91.
2002: Sharon H Giordano; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi
Efficacy of anastrozole in male breast cancer.
American journal of clinical oncology 2002;25(3):235-7.
2002: Gabriel N Hortobagyi
Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
Clinical breast cancer 2002;3 Suppl 1():34-8.
2002: Edgardo Rivera; Vicente Valero; Massimo Cristofanilli; Debra Frye; Daniel J Booser; Marguerite Rosales; Gabriel N Hortobagyi
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.
Cancer 2002;94(9):2321-6.
2002: Aman U Buzdar; S Eva Singletary; Vicente Valero; Daniel J Booser; Nuhad K Ibrahim; Zia Rahman; Richard L Theriault; Ronald Walters; Edgardo Rivera; Terry L Smith; Frankie A Holmes; Emma Hoy; Debra Frye; Nikki Manuel; Shu-Wan Kau; Marsha D McNeese; Eric A Strom; Eva Thomas; Kelly Hunt; Frederick C Ames; Donald Berry; Gabriel N Hortobagyi
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1073-9.
2002: Nuhad K Ibrahim; Neil Desai; Sewa S Legha; Patrick Soon-Shiong; Richard L Theriault; Edgardo Rivera; Bita Esmaeli; Sigrid E Ring; Agop Bedikian; Gabriel N Hortobagyi; Julie A Ellerhorst
Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1038-44.
2002: Gabriel N Hortobagyi
The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
Journal of the National Cancer Institute 2002;94(9):641-3.
2002: Funda Meric; Mien-Chie Hung; Gabriel N Hortobagyi; Kelly K Hunt
HER2/neu in the management of invasive breast cancer.
Journal of the American College of Surgeons 2002;194(4):488-501.
2002: Francisco J Esteva; Vicente Valero; Daniel J Booser; Laura T Guerra; James L Murray; Lajos Pusztai; Massimo Cristofanilli; Banu Arun; Bita Esmaeli; Herbert A Fritsche; Nour Sneige; Terry L Smith; Gabriel N Hortobagyi
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1800-8.
2002: Edgardo Rivera; Vicente Valero; Francisco J Esteva; Laura Syrewicz; Massimo Cristofanilli; Zia Rahman; Daniel J Booser; Gabriel N Hortobagyi
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
Cancer chemotherapy and pharmacology 2002;49(4):299-302.
2002: Banu Arun; Gabriel N Hortobagyi
Progress in breast cancer chemoprevention.
Endocrine-related cancer 2002;9(1):15-32.
2002: Edgardo Rivera; Linda Sutton; Bruce Colwell; Mark Graham II; Debra Frye; Matt Somerville; Heather S Conklin; Chip McGuirt; Jeremey Levin; Gabriel N Hortobagyi
Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):987-93.
2002: Bita Esmaeli; Gabriel N Hortobagyi; Francisco J Esteva; Vicente Valero; M Amir Ahmadi; Daniel J Booser; Nuhad Ibrahim; Ebrahim S Delpassand; Rebecca Arbuckle
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):218-21.
2002: Massimo Cristofanilli; Giovanni De Gasperis; Lisha Zhang; Mien-Chie Hung; Peter R C Gascoyne; Gabriel N Hortobagyi
Automated electrorotation to reveal dielectric variations related to HER-2/neu overexpression in MCF-7 sublines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):615-9.
2002: Gabriel N Hortobagyi
Can we cure limited metastatic breast cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):620-3.
2002: Edgardo Rivera; Frankie A Holmes; Aman U Buzdar; Lina Asmar; Shu-Wan Kau; Giuseppe Fraschini; Ronald Walters; Richard L Theriault; Gabriel N Hortobagyi
Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.
The breast journal 2002;8(1):2-9.
2002: Nuhad K Ibrahim; Zia Rahman; Vicente Valero; James L Murray; Debra Frye; Gabriel N Hortobagyi
Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.
Cancer investigation 2002;20(1):29-37.
2002: Thomas Buchholz; Susan L Tucker; Lawrence Masullo; Henry M Kuerer; Jessica Erwin; Jessica Salas; Debra Frye; Eric A Strom; Marsha D McNeese; George Perkins; Angela Katz; S Eva Singletary; Kelly K Hunt; Aman U Buzdar; Gabriel N Hortobagyi
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):17-23.
2001: N Sneige; B Kemp; L Pusztai; L Asmar; Gabriel N Hortobagyi
Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance.
Breast (Edinburgh, Scotland) 2001;10(6):492-500.
2001: Henry M Kuerer; S Eva Singletary; Aman U Buzdar; Frederick C Ames; V Valero; Thomas Buchholz; Merrick I Ross; L Pusztai; Gabriel N Hortobagyi; Kelly K Hunt
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma.
American journal of surgery 2001;182(6):601-8.
2001: Gabriel N Hortobagyi
Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer.
Seminars in oncology 2001;28(6 Suppl 18):43-7.
2001: S C Wang; Lidong Zhang; Gabriel N Hortobagyi; Mien-Chie Hung
Targeting HER2: recent developments and future directions for breast cancer patients.
Seminars in oncology 2001;28(6 Suppl 18):21-9.
2001: Q Xiong; Vicente Valero; V Kau; Shu-Wan Kau; S Taylor; Terry L Smith; Aman U Buzdar; Gabriel N Hortobagyi; Richard L Theriault
Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience.
Cancer 2001;92(10):2523-8.
2001: Massimo Cristofanilli; Aman U Buzdar; Nour Sneige; Terry Smith; BJ Wasaff; Nuhad Ibrahim; Daniel J Booser; Edgardo Rivera; James L Murray; Vicente Valero; Naoto T Ueno; Eva Singletary; Kelly Hunt; Eric A Strom; Marsha D McNeese; Carol B Stelling; Gabriel N Hortobagyi
Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.
Cancer 2001;92(7):1775-82.
2001: Gabriel N Hortobagyi; E A Perez
Integration of trastuzumab into adjuvant systemic therapy of breast cancer: ongoing and planned clinical trials.
Seminars in oncology 2001;28(5 Suppl 16):41-6.
2001: Gabriel N Hortobagyi
Optimal duration of therapy with trastuzumab.
Seminars in oncology 2001;28(5 Suppl 16):33-40.
2001: Thomas Buchholz; B S Hill; Susan L Tucker; Debra Frye; Henry M Kuerer; A U Buzdar; M D McNeese; S Eva Singletary; Naoto T Ueno; Lajos Pusztai; Vicente Valero; Gabriel N Hortobagyi
Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
Cancer journal (Sudbury, Mass.) 2001;7(5):413-20.
2001: Georges Vlastos; Nadeem Q Mirza; Funda Meric; Kelly K Hunt; Henry M Kuerer; Frederick C Ames; Merrick I Ross; Thomas Buchholz; Gabriel N Hortobagyi; S Eva Singletary
Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience.
Cancer 2001;92(5):1092-100.
2001: S M Ali; F J Esteva; Gabriel N Hortobagyi; H Harvey; J Seaman; R Knight; L Costa; A Lipton
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3434-7.
2001: Gabriel N Hortobagyi; Naoto T Ueno; Weiya Xia; S Zhang; Judith K Wolf; Joe B Putnam; P L Weiden; Jie S Willey; M Carey; D L Branham; J Y Payne; SD Tucker; Chandra Bartholomeusz; RG Kilbourn; Robert L De Jager; Nour Sneige; Ruth Katz; Pervin Anklesaria; Nuhad K Ibrahim; James L Murray; Richard L Theriault; Vicente Valero; David M Gershenson; M W Bevers; Leaf Huang; Gabriel Lopez-Berestein; Mien-Chie Hung
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3422-33.
2001: Gabriel N Hortobagyi
Adjuvant systemic therapy for early breast cancer: progress and controversies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):1839-42.
2001: Richard L Theriault; Gabriel N Hortobagyi
The evolving role of bisphosphonates.
Seminars in oncology 2001;28(3):284-90.
2001: Andrew D Seidman; Monica Fornier; Francisco J Esteva; Lee Tan; S Kaptain; Ariadne M Bach; Katherine S Panageas; Crispinita D Arroyo; V Valero; Violante E Currie; Teresa A Gilewski; Maria Theodoulou-Haber; Mary Ellen Moynahan; Mark M Moasser; Nancy T Sklarin; Maura Dickler; Gabriella D'Andrea-Carlino; M Cristofanilli; E Rivera; Gabriel N Hortobagyi; Larry Norton; Clifford Hudis
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2587-95.
2001: Thomas Buchholz; Susan L Tucker; J Erwin; D Mathur; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi; Massimo Cristofanilli; Francisco J Esteva; Lisa A Newman; S Eva Singletary; Aman U Buzdar; Kelly K Hunt
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2240-6.
2001: Gabriel N Hortobagyi
Unmet needs in metastatic bone disease and its complications: is progress possible?
Seminars in oncology 2001;28(2 Suppl 6):1-3.
2001: Edgardo Rivera; Vicente Valero; L Syrewicz; Zia Rahman; Francisco J Esteva; Richard L Theriault; Marguerite Rosales; Daniel J Booser; James L Murray; Robert C Bast; Gabriel N Hortobagyi; F L Esteva
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1716-22.
2001: Nuhad K Ibrahim; Aman U Buzdar; Vicente Valero; Kapil Dhingra; Jie Willey; Gabriel N Hortobagyi
Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.
Cancer 2001;91(4):664-71.
2001: Gabriel N Hortobagyi
Treatment of advanced breast cancer with gemcitabine and vinorelbine.
Oncology (Williston Park, N.Y.) 2001;15(2 Suppl 3):15-7.
2001: R A Brito; Vicente Valero; Aman U Buzdar; Daniel J Booser; Frederick C Ames; Eric A Strom; M Ross; Richard L Theriault; Debra Frye; Shu-Wan Kau; Lina Asmar; Marsha D McNeese; S Eva Singletary; Gabriel N Hortobagyi
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):628-33.
2001: Massimo Cristofanilli; Gabriel N Hortobagyi
New horizons in treating metastatic disease.
Clinical breast cancer 2001;1(4):276-87.
2001: Gabriel N Hortobagyi
Progress in systemic chemotherapy of primary breast cancer: an overview.
Journal of the National Cancer Institute. Monographs 2001;(30):72-9.
2001: Nuhad K Ibrahim; Vicente Valero; Zia Rahman; Richard L Theriault; Ronald S Walters; Aman U Buzdar; Daniel J Booser; Frankie A Holmes; James L Murray; Jie Willey; Robert C Bast; Gabriel N Hortobagyi
Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.
Cancer investigation 2001;19(5):459-66.
2000: Edith A Perez; Gabriel N Hortobagyi
Ongoing and planned adjuvant trials with trastuzumab.
Seminars in oncology 2000;27(6 Suppl 11):26-32; discussion 92-100.
2000: Nuhad K Ibrahim; Aman U Buzdar; Lina Asmar; Richard L Theriault; Gabriel N Hortobagyi
Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1597-601.
2000: Edgardo Rivera; Frankie A Holmes; Debra Frye; Vicente Valero; Richard L Theriault; Daniel J Booser; Ronald Walters; Aman U Buzdar; Kapil Dhingra; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
Cancer 2000;89(11):2195-201.
2000: Laura B Michaud; Vicente Valero; Gabriel N Hortobagyi
Risks and benefits of taxanes in breast and ovarian cancer.
Drug safety : an international journal of medical toxicology and drug experience 2000;23(5):401-28.
2000: Laura M Freedman; Thomas Buchholz; Howard D Thames; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi; S Eva Singletary; KM Heaton; Kelly K Hunt
Local-regional control in breast cancer patients with a possible genetic predisposition.
International journal of radiation oncology, biology, physics 2000;48(4):951-7.
2000: Tara M Breslin; Lorenzo Cohen; Aysegul Sahin; Jason Fleming; Henry M Kuerer; Lisa A Newman; Ebrahim S Delpassand; R House; Frederick C Ames; Barry W Feig; Merrick I Ross; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobagyi; Kelly K Hunt
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3480-6.
2000: Nadeem Q Mirza; Georges Vlastos; Funda Meric; Aysegul A Sahin; S Eva Singletary; Lisa A Newman; Henry M Kuerer; Frederick C Ames; Merrick I Ross; Barry W Feig; Raphael E Pollock; Thomas Buchholz; Marsha D McNeese; Eric A Strom; Gabriel N Hortobagyi; Kelly K Hunt
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
Annals of surgical oncology 2000;7(9):656-64.
2000: Angela Katz; Eric A Strom; Thomas Buchholz; Howard D Thames; C D Smith; Anuja Jhingran; Gabriel N Hortobagyi; Aman U Buzdar; Richard Theriault; S Eva Singletary; Marsha D McNeese
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(15):2817-27.
2000: Marjorie C Green; James L Murray; Gabriel N Hortobagyi
Monoclonal antibody therapy for solid tumors.
Cancer treatment reviews 2000;26(4):269-86.
2000: Funda Meric; Nadeem Q Mirza; Aman U Buzdar; Kelly K Hunt; Frederick C Ames; Merrick I Ross; Raphael E Pollock; Lisa A Newman; Barry W Feig; Eric A Strom; Thomas Buchholz; Marsha D McNeese; Gabriel N Hortobagyi; S Eva Singletary
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.
Annals of surgical oncology 2000;7(6):435-40.
2000: Gabriel N Hortobagyi
Developments in chemotherapy of breast cancer.
Cancer 2000;88(12 Suppl):3073-9.
2000: Paulo M Hoff; Vicente Valero; Aman U Buzdar; S Eva Singletary; Richard L Theriault; Daniel J Booser; Lina Asmar; Debra Frye; Marsha D McNeese; Gabriel N Hortobagyi
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
Cancer 2000;88(9):2054-60.
2000: Nuhad K Ibrahim; Vicente Valero; Richard L Theriault; Jie Willey; Ronald S Walters; Aman U Buzdar; Daniel J Booser; Gabriel N Hortobagyi
Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.
American journal of clinical oncology 2000;23(2):117-21.
2000: Xavier Pivot; L Asmar; Gabriel N Hortobagyi; Richard Theriault; F Pastorini; A Buzdar
A retrospective study of first indicators of breast cancer recurrence.
Oncology 2000;58(3):185-90.
2000: Allan Lipton; Richard L Theriault; Gabriel N Hortobagyi; Joe Simeone; Robert D Knight; K Mellars; Dirk Reitsma; M Heffernan; John Seaman
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.
Cancer 2000;88(5):1082-90.
2000: J M Dixon; Gabriel N Hortobagyi
Treating young patients with breast cancer. The evidence suggests that all should be treated with adjuvant therapy.
BMJ (Clinical research ed.) 2000;320(7233):457-8.
2000: Gabriel N Hortobagyi; Aman U Buzdar; Richard L Theriault; Vicente Valero; Debra Frye; Daniel J Booser; Frankie A Holmes; Sergio Giralt; Issa Khouri; Borje Andersson; James L Gajewski; Gabriela Rondon; T L Smith; S E Singletary; F C Ames; N Sneige; Eric A Strom; Marsha D McNeese; Albert Deisseroth; Richard E Champlin
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Journal of the National Cancer Institute 2000;92(3):225-33.
2000: Robert Peter Gale; RE Park; R Dubois; Jacob Bitran; A Buzdar; Gabriel N Hortobagyi; Stephen E Jones; G S Lazar; Gary Spitzer; S M Swain; C B Vaughn; C E Vogel; S Martino
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
Clinical transplantation 2000;14(1):32-41.
2000: Daniel J Booser; Ronald S Walters; Frankie A Holmes; Gabriel N Hortobagyi
Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatin for relapsed metastatic breast cancer: a phase II study.
American journal of clinical oncology 2000;23(1):40-1.
2000: Xavier Pivot; L Asmar; A U Buzdar; V Valero; Gabriel N Hortobagyi
A unified definition of clinical anthracycline resistance breast cancer.
British journal of cancer 2000;82(3):529-34.
2000: Nuhad K Ibrahim; A A Sahin; R A Dubrow; P M Lynch; L Boehnke-Michaud; Vicente Valero; Aman U Buzdar; Gabriel N Hortobagyi
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
Lancet 2000;355(9200):281-3.
2000: Thomas Buchholz; Susan L Tucker; R A Moore; Marsha D McNeese; Eric A Strom; A Jhingrin; Gabriel N Hortobagyi; S Eva Singletary; R E Champlin
Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant.
International journal of radiation oncology, biology, physics 2000;46(2):337-43.
2000: Daniel J Booser; Roman Perez-Soler; P Cossum; Laura Guerra; Qing-Ping Wu; Yiyu Zou; Waldemar Priebe; Gabriel N Hortobagyi
Phase I study of liposomal annamycin.
Cancer chemotherapy and pharmacology 2000;46(5):427-32.
2000: Francisco J Esteva; L T Soh; Frankie A Holmes; William Plunkett; Christina A Meyers; Arthur Forman; Gabriel N Hortobagyi
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.
Cancer chemotherapy and pharmacology 2000;46(5):382-6.
2000: Mien-Chie Hung; Gabriel N Hortobagyi; Naoto T Ueno
Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer.
Advances in experimental medicine and biology 2000;465():171-80.
2000: Gabriel N Hortobagyi
Adjuvant therapy for breast cancer.
Annual review of medicine 2000;51():377-92.
2000: P P Major; A Lipton; J Berenson; Gabriel N Hortobagyi
Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Cancer 2000;88(1):6-14.
1999: Jeffrey T Lenert; Georges Vlastos; Nadeem Q Mirza; D J Winchester; SM Binkley; Frederick C Ames; Merrick I Ross; Barry W Feig; Kelly K Hunt; Eric A Strom; Aman U Buzdar; Gabriel N Hortobagyi; S Eva Singletary
Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients.
Annals of surgical oncology 1999;6(8):762-7.
1999: Gabriel N Hortobagyi
High-dose chemotherapy for primary breast cancer: facts versus anecdotes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11 Suppl):25-9.
1999: Aman U Buzdar; S Eva Singletary; Richard L Theriault; Daniel J Booser; Vicente Valero; Nuhad Ibrahim; Terry L Smith; Lina Asmar; Debra Frye; N Manuel; Shu-Wan Kau; Marsha D McNeese; Eric A Strom; Kelly Hunt; Frederick C Ames; Gabriel N Hortobagyi
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3412-7.
1999: F J Esteva; Gabriel N Hortobagyi
Adjuvant systemic therapy for primary breast cancer.
The Surgical clinics of North America 1999;79(5):1075-90.
1999: Lajos Pusztai; F J Esteva; M Cristofanilli; Mien-Chie Hung; Gabriel N Hortobagyi
Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.
Cancer treatment reviews 1999;25(5):271-7.
1999: Nuhad K Ibrahim; Zia Rahman; Vicente Valero; Jie Willey; Richard L Theriault; Aman U Buzdar; James L Murray; Robert C Bast; Gabriel N Hortobagyi
Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.
Cancer 1999;86(7):1251-7.
1999: Nuhad K Ibrahim; Gabriel N Hortobagyi
The evolving role of specific estrogen receptor modulators (SERMs)
Surgical oncology 1999;8(2):103-23.
1999: Aman U Buzdar; Gabriel N Hortobagyi
Recent advances in adjuvant therapy of breast cancer.
Seminars in oncology 1999;26(4 Suppl 12):21-7.
1999: Gabriel N Hortobagyi; Mien-Chie Hung; Aman U Buzdar
Recent developments in breast cancer therapy.
Seminars in oncology 1999;26(4 Suppl 12):11-20.
1999: Xavier Pivot; L Asmar; Gabriel N Hortobagyi
The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review).
International journal of oncology 1999;15(2):381-6.
1999: Henry M Kuerer; Aysegul A Sahin; Kelly K Hunt; Lisa A Newman; Tara M Breslin; Frederick C Ames; Merrick I Ross; Aman U Buzdar; Gabriel N Hortobagyi; S Eva Singletary
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Annals of surgery 1999;230(1):72-8.
1999: Gabriel N Hortobagyi
Recent progress in the clinical development of docetaxel (Taxotere).
Seminars in oncology 1999;26(3 Suppl 9):32-6.
1999: Lajos Pusztai; Lina Asmar; T L Smith; Gabriel N Hortobagyi
Relapse after complete response to anthracycline-based combination chemotherapy in metastatic breast cancer.
Breast cancer research and treatment 1999;55(1):1-8.
1999: Thomas Buchholz; Kelly K Hunt; C M Amosson; S L Tucker; Eric A Strom; Marsha D McNeese; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi
Sequencing of chemotherapy and radiation in lymph node-negative breast cancer.
The cancer journal from Scientific American 1999;5(3):159-64.
1999: Rena Vassilopoulou-Sellin; Lina Asmar; Gabriel N Hortobagyi; Mary Jean Klein; Marsha D McNeese; S Eva Singletary; Richard L Theriault
Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1482-7.
1999: Vicente Valero; Aman U Buzdar; Richard L Theriault; Nozar Azarnia; G A Fonseca; Jie Willey; Michael S Ewer; Ronald S Walters; B Mackay; Donald A Podoloff; Daniel J Booser; L W Lee; Gabriel N Hortobagyi
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1425-34.
1999: M Cristofanilli; Frankie A Holmes; L Esparza; V Valero; Aman U Buzdar; J A Neidhart; Gabriel N Hortobagyi
Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.
Breast cancer research and treatment 1999;54(3):225-33.
1999: Frankie A Holmes; Vicente Valero; Ronald S Walters; Richard L Theriault; Daniel J Booser; H Gibbs; Giuseppe Fraschini; Aman U Buzdar; Jie Willey; Debra Frye; Lina Asmar; Gabriel N Hortobagyi
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):403-11.
1999: F J Esteva; Gabriel N Hortobagyi
Locally advanced breast cancer.
Hematology/oncology clinics of North America 1999;13(2):457-72, vii.
1999: D L Berry; Richard L Theriault; Frankie A Holmes; Valerie Parisi; Daniel J Booser; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobagyi
Management of breast cancer during pregnancy using a standardized protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):855-61.
1999: Richard L Theriault; Allan Lipton; Gabriel N Hortobagyi; R Leff; Stefan Gluck; J F Stewart; S Costello; I Kennedy; Joe Simeone; John Seaman; Robert D Knight; K Mellars; M Heffernan; Dirk Reitsma
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):846-54.
1999: Henry M Kuerer; Lisa A Newman; Terry L Smith; Frederick C Ames; Kelly K Hunt; Kapil Dhingra; Richard L Theriault; G Singh; SM Binkley; Nour Sneige; Thomas Buchholz; Merrick I Ross; Marsha D McNeese; Aman U Buzdar; Gabriel N Hortobagyi; S Eva Singletary
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):460-9.
1999: Lisha Zhang; Yiu-Keung Lau; Weiya Xia; Gabriel N Hortobagyi; Mien-Chie Hung
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):343-53.
1999: Nuhad K Ibrahim; Gabriel N Hortobagyi; Michael S Ewer; M K Ali; Lina Asmar; Richard L Theriault; Giuseppe Fraschini; Debra Frye; Aman U Buzdar
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.
Cancer chemotherapy and pharmacology 1999;43(6):471-8.
1999: L Pusztai; Frankie A Holmes; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy.
Cancer chemotherapy and pharmacology 1999;43(1):86-91.
1999: Zia Rahman; Debra Frye; Terry L Smith; Lina Asmar; Richard L Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference.
Cancer 1999;85(1):104-11.
1998: Allan Lipton; Laurence Demers; E Curley; Vernon M Chinchilli; L Gaydos; Gabriel N Hortobagyi; Richard Theriault; D Clemens; L Costa; J Seaman; R Knight
Markers of bone resorption in patients treated with pamidronate.
European journal of cancer (Oxford, England : 1990) 1998;34(13):2021-6.
1998: Henry M Kuerer; Lisa A Newman; Aman U Buzdar; Kelly K Hunt; Kapil Dhingra; Thomas Buchholz; SM Binkley; Frederick C Ames; Barry W Feig; Merrick I Ross; Gabriel N Hortobagyi; S Eva Singletary
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
American journal of surgery 1998;176(6):502-9.
1998: Henry M Kuerer; Lisa A Newman; Bruno D Fornage; Kapil Dhingra; Kelly K Hunt; Aman U Buzdar; Frederick C Ames; Merrick I Ross; Barry W Feig; Gabriel N Hortobagyi; S Eva Singletary
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.
Annals of surgical oncology 1998;5(8):673-80.
1998: Gabriel N Hortobagyi
An expanding role for docetaxel.
Seminars in oncology 1998;25(6 Suppl 13):1-3.
1998: M Cristofanilli; Gabriel N Hortobagyi
Current methods to prevent the development of breast cancer.
In vivo (Athens, Greece) 1998;12(6):659-65.
1998: M Cristofanilli; W J Bryan; L L Miller; ALEX CHANG; W J Gradishar; Donald Kufe; Gabriel N Hortobagyi
Phase II study of adozelesin in untreated metastatic breast cancer.
Anti-cancer drugs 1998;9(9):779-82.
1998: L Pusztai; Ronald S Walters; Vicente Valero; Richard L Theriault; Gabriel N Hortobagyi
Daily oral etoposide in patients with heavily pretreated metastatic breast cancer.
American journal of clinical oncology 1998;21(5):442-6.
1998: Vicente Valero; Stephen E Jones; Daniel Von Hoff; Daniel J Booser; Robert G Mennel; Peter M Ravdin; Frankie A Holmes; Zia Rahman; M W Schottstaedt; J K Erban; Laura Guerra; R H Earhart; Gabriel N Hortobagyi; Howard A Burris
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3362-8.
1998: Gabriel N Hortobagyi
Treatment of breast cancer.
The New England journal of medicine 1998;339(14):974-84.
1998: L Pusztai; Gabriel N Hortobagyi
Discouraging news for high-dose chemotherapy in high-risk breast cancer.
Lancet 1998;352(9127):501-2.
1998: Gabriel N Hortobagyi; Mien-Chie Hung; Gabriel Lopez-Berestein
A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer.
Human gene therapy 1998;9(12):1775-98.
1998: Z U Rahman; Gabriel N Hortobagyi; Aman U Buzdar; R Champlin
High-dose chemotherapy with autologous stem cell support in patients with breast cancer.
Cancer treatment reviews 1998;24(4):249-63.
1998: Ronald S Walters; Frankie A Holmes; Vicente Valero; Laura Guerra; Gabriel N Hortobagyi
Phase II study of ifosfamide and mesna in patients with metastatic breast cancer.
American journal of clinical oncology 1998;21(4):413-5.
1998: N K Ibrahim; Gabriel N Hortobagyi
New antiestrogens in breast cancer: a review.
The breast journal 1998;4(4):213-29.
1998: Henry M Kuerer; Lisa A Newman; Aman U Buzdar; Kapil Dhingra; Kelly K Hunt; Thomas Buchholz; SM Binkley; Eric A Strom; Frederick C Ames; Merrick I Ross; Barry W Feig; Marsha D McNeese; Gabriel N Hortobagyi; S Eva Singletary
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
The cancer journal from Scientific American 1998;4(4):230-6.
1998: Gabriel N Hortobagyi
Progress in endocrine therapy for breast carcinoma.
Cancer 1998;83(1):1-6.
1998: Lisha Zhang; Yiu-Keung Lau; L Xi; R L Hong; D S Kim; C F Chen; Gabriel N Hortobagyi; C Chang; Mien-Chie Hung
Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.
Oncogene 1998;16(22):2855-63.
1998: Gabriel N Hortobagyi; Richard L Theriault; Allan Lipton; L Porter; Douglas W Blayney; C Sinoff; H Wheeler; Joe Simeone; John Seaman; Robert D Knight; M Heffernan; K Mellars; Dirk Reitsma
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2038-44.
1998: Dihua Yu; Bolin Liu; Tong Jing; D Sun; Janet E Price; S E Singletary; N Ibrahim; Gabriel N Hortobagyi; Mien-Chie Hung
Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.
Oncogene 1998;16(16):2087-94.
1998: EA Diaz-Canton; Vicente Valero; Zia Rahman; EJ Rodriguez-Monge; Debra Frye; T Smith; Aman U Buzdar; Gabriel N Hortobagyi
Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):413-8.
1998: Kapil Dhingra; Aysegul Sahin; K Emami; Gabriel N Hortobagyi; Zeev Estrov
Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
Breast cancer research and treatment 1998;48(2):165-74.
1998: Aman U Buzdar; Gabriel N Hortobagyi
Update on endocrine therapy for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):527-34.
1998: Naoto T Ueno; Gabriela Rondón; Nadeem Q Mirza; Deborah Geisler; Paolo Anderlini; Sergio Giralt; Borje S Andersson; David F Claxton; James L Gajewski; Issa F Khouri; Martin Körbling; RC Mehra; Donna Przepiorka; Zia Rahman; Barry Samuels; Koen van Besien; Gabriel N Hortobagyi; Richard E Champlin
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):986-93.
1998: Paulo M Hoff; Vicente Valero; Nuhad Ibrahim; Jie Willey; Gabriel N Hortobagyi
Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.
Cancer 1998;82(5):965-9.
1998: Gabriel N Hortobagyi; Aman U Buzdar
Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.
Cancer investigation 1998;16(6):385-90.
1997: A Y Kinney; Aysegul Sahin; Sally W Vernon; Ralph F Frankowski; John F Annegers; Gabriel N Hortobagyi; Aman U Buzdar; Debra Frye; Kapil Dhingra
The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy.
Cancer 1997;80(12):2240-9.
1997: Xiao-Chun Xu; Nour Sneige; Xiaojun Liu; R Nandagiri; J Jack Lee; Farzana Lukmanji; Gabriel N Hortobagyi; Scott M Lippman; Kapil Dhingra; Reuben Lotan
Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.
Cancer research 1997;57(22):4992-6.
1997: Clifford Hudis; L Riccio; F Holmes; Andrew D Seidman; José Baselga; Violante E Currie; DW Fennelly; Teresa A Gilewski; Mary Ellen Moynahan; G Raptis; Nancy T Sklarin; A Surbone; M Uhlenhopp; N Maickel; Tzy-Jyun Yao; S Hellmann; J Usakewicz; Gabriel N Hortobagyi; Larry Norton
Phase II study of semisynthetic paclitaxel in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(13):2198-202.
1997: Frankie A Holmes; A Lopez; Giora Mavligit; Giuseppe Fraschini; Debra Frye; Gabriel N Hortobagyi
Secondary drug resistance in breast cancer: failure to reverse with oral nifedipine.
International journal of cancer. Journal international du cancer 1997;73(2):184-6.
1997: Zia Rahman; Richard Champlin; Gabriela Rondon; Debra Frye; Vicente Valero; RC Mehra; Gabriel N Hortobagyi
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-77-S17-80.
1997: Gabriel N Hortobagyi; Jie Willey; Zia Rahman; Frankie A Holmes; Richard L Theriault; Aman U Buzdar
Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-65-S17-68.
1997: Aman U Buzdar; Gabriel N Hortobagyi; Lina Asmar; Richard L Theriault; Zia Rahman; Marsha D McNeese; S Eva Singletary; Frederick C Ames
Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-31-S17-34.
1997: Gabriel N Hortobagyi
Chemotherapy of breast cancer: a historical perspective.
Seminars in oncology 1997;24(5 Suppl 17):S17-1-S17-4.
1997: Zia Rahman; Debra Frye; Aman U Buzdar; Terry L Smith; Lina Asmar; Richard E Champlin; Gabriel N Hortobagyi
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3171-7.
1997: J Herrada; Revathy B Iyer; E Neely Atkinson; Nour Sneige; Aman U Buzdar; Gabriel N Hortobagyi
Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1565-9.
1997: A U Buzdar; L Asmar; Gabriel N Hortobagyi
Impact of patient characteristics on treatment outcome: anthracycline resistance.
European journal of cancer (Oxford, England : 1990) 1997;33 Suppl 7():S3-6.
1997: Gabriel N Hortobagyi
Docetaxel: today's results and tomorrow's promises.
Oncology (Williston Park, N.Y.) 1997;11(8 Suppl 8):11-4.
1997: Gabriel N Hortobagyi
Introduction: taxoids and the management of breast cancer.
Seminars in oncology 1997;24(4 Suppl 13):S13-1-S13-2.
1997: Gabriel N Hortobagyi; Frankie A Holmes; Richard L Theriault; Zia Rahman; Aman U Buzdar
Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer.
Seminars in oncology 1997;24(4 Suppl 11):S11-13-S11-19.
1997: Daniel W Chan; R A Beveridge; Hyman Muss; Herbert A Fritsche; Gabriel N Hortobagyi; Richard Theriault; D Kiang; B J Kennedy; M Evelegh
Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2322-8.
1997: Zia Rahman; Laura Guerra; H Y Yap; Giuseppe Fraschini; Gerald P Bodey; Gabriel N Hortobagyi
Chemotherapy-induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapy.
Cancer 1997;79(6):1150-7.
1997: Gabriel N Hortobagyi
Paclitaxel-based combination chemotherapy for breast cancer.
Oncology (Williston Park, N.Y.) 1997;11(3 Suppl 2):29-37.
1997: J Y Chang; Weiya Xia; Ruping Shao; F Sorgi; Gabriel N Hortobagyi; Leaf Huang; Mien-Chie Hung
The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
Oncogene 1997;14(5):561-8.
1997: Gabriel N Hortobagyi; Frankie A Holmes; N Ibrahim; Richard Champlin; Aman U Buzdar
The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S30-3.
1997: Gabriel N Hortobagyi; Frankie A Holmes
Optimal dosing of paclitaxel and doxorubicin in metastatic breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S4-7.
1997: Naoto T Ueno; Aman U Buzdar; S E Singletary; F C Ames; Marsha D McNeese; Frankie A Holmes; Richard L Theriault; Eric A Strom; BJ Wasaff; Lina Asmar; Debra Frye; Gabriel N Hortobagyi
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
Cancer chemotherapy and pharmacology 1997;40(4):321-9.
1996: E G Hanania; R E Giles; John Kavanagh; SQ Fu; D Ellerson; Z Zu; T Wang; Y Su; Andrzej P Kudelka; Zia Rahman; Frankie A Holmes; Gabriel N Hortobagyi; David F Claxton; CR Bachier; Peter F Thall; S Cheng; Jeane Hester; J M Ostrove; R E Bird; A Chang; Martin Korbling; D Seong; Richard J Cote; Tatyana A Holzmayer; Albert Deisseroth
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15346-51.
1996: Gabriel N Hortobagyi; Richard L Theriault; L Porter; Douglas W Blayney; Allan Lipton; C Sinoff; H Wheeler; Joe Simeone; John Seaman; Robert D Knight
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
The New England journal of medicine 1996;335(24):1785-91.
1996: C M Anderson; Ronald S Walters; Gabriel N Hortobagyi
Mediastinitis related to probable central vinblastine extravasation in a woman undergoing adjuvant chemotherapy for early breast cancer.
American journal of clinical oncology 1996;19(6):566-8.
1996: Gabriel N Hortobagyi; M J Piccart-Gebhart
Current management of advanced breast cancer.
Seminars in oncology 1996;23(5 Suppl 11):1-5.
1996: E Diamandidou; Aman U Buzdar; Terry L Smith; Debra Frye; M Witjaksono; Gabriel N Hortobagyi
Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2722-30.
1996: Frankie A Holmes; Timothy Madden; Robert A Newman; Vicente Valero; Richard L Theriault; Giuseppe Fraschini; Ronald S Walters; Daniel J Booser; Aman U Buzdar; Jie Willey; Gabriel N Hortobagyi
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2713-21.
1996: Aman U Buzdar; P V Plourde; Gabriel N Hortobagyi
Aromatase inhibitors in metastatic breast cancer.
Seminars in oncology 1996;23(4 Suppl 9):28-32.
1996: Kapil Dhingra; Gabriel N Hortobagyi
Critical evaluation of prognostic factors.
Seminars in oncology 1996;23(4):436-45.
1996: P A Greenberg; Gabriel N Hortobagyi; Terry L Smith; L D Ziegler; Debra Frye; Aman U Buzdar
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(8):2197-205.
1996: Nuhad K Ibrahim; Debra Frye; Aman U Buzdar; Ronald S Walters; Gabriel N Hortobagyi
Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome.
Archives of internal medicine 1996;156(8):882-8.
1996: Kelly K Hunt; F C Ames; S E Singletary; A U Buzdar; Gabriel N Hortobagyi
Locally advanced noninflammatory breast cancer.
The Surgical clinics of North America 1996;76(2):393-410.
1996: Albert Deisseroth; Frankie A Holmes; Gabriel N Hortobagyi; Richard Champlin
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
Human gene therapy 1996;7(3):401-16.
1996: Gabriel N Hortobagyi; N Ibrahim
Paclitaxel-containing combination chemotherapy for metastatic breast cancer.
Seminars in oncology 1996;23(1 Suppl 1):53-7.
1996: Gabriel N Hortobagyi; Frankie A Holmes
Single-agent paclitaxel for the treatment of breast cancer: an overview.
Seminars in oncology 1996;23(1 Suppl 1):4-9.
1996: T Chen; Kapil Dhingra; Aysegul Sahin; Nour Sneige; Gabriel N Hortobagyi; C M Aldaz
Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
Breast cancer research and treatment 1996;39(2):177-85.
1996: Richard L Theriault; Ronald S Walters; Frankie A Holmes; Laura Guerra; C Kowal; Gabriel N Hortobagyi
A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.
Cancer chemotherapy and pharmacology 1996;38(3):289-91.
1996: K Hoffman; Frankie A Holmes; Giuseppe Fraschini; L Esparza; Debra Frye; Martin N Raber; Robert A Newman; Gabriel N Hortobagyi
Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.
Cancer chemotherapy and pharmacology 1996;37(3):254-8.
1995: Vicente Valero; Frankie A Holmes; Ronald S Walters; Richard L Theriault; L Esparza; Giuseppe Fraschini; G A Fonseca; R E Bellet; Aman U Buzdar; Gabriel N Hortobagyi
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2886-94.
1995: E G Hanania; John Kavanagh; Gabriel N Hortobagyi; R E Giles; Richard Champlin; Albert Deisseroth
Recent advances in the application of gene therapy to human disease.
The American journal of medicine 1995;99(5):537-52.
1995: Aman U Buzdar; S Eva Singletary; Daniel J Booser; Debra Frye; B Wasaff; Gabriel N Hortobagyi
Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.
Surgical oncology clinics of North America 1995;4(4):715-34.
1995: S Eva Singletary; Gabriel N Hortobagyi; Stephen S Kroll
Surgical and medical management of local-regional treatment failures in advanced primary breast cancer.
Surgical oncology clinics of North America 1995;4(4):671-84.
1995: Gabriel N Hortobagyi
Management of breast cancer: status and future trends.
Seminars in oncology 1995;22(5 Suppl 12):101-7.
1995: Gabriel N Hortobagyi
Innovative approaches to breast cancer treatment: the role of paclitaxel. Introduction.
Seminars in oncology 1995;22(4 Suppl 8):1-2.
1995: Aman U Buzdar; Frankie A Holmes; Gabriel N Hortobagyi
Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience.
Seminars in oncology 1995;22(3 Suppl 6):101-4.
1995: Gabriel N Hortobagyi
Future directions for vinorelbine (Navelbine).
Seminars in oncology 1995;22(2 Suppl 5):80-6; discussion 86-7.
1995: I A Jaiyesimi; Aman U Buzdar; D A Decker; Gabriel N Hortobagyi
Use of tamoxifen for breast cancer: twenty-eight years later.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):513-29.
1994: S H Cho; Aysegul Sahin; Gabriel N Hortobagyi; Walter N Hittelman; Kapil Dhingra
Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy.
Cancer research 1994;54(24):6302-5.
1994: Gabriel N Hortobagyi; Frankie A Holmes; R L Theriault; Aman U Buzdar
Use of Taxol (paclitaxel) in breast cancer.
Oncology 1994;51 Suppl 1():29-32.
1994: P Beitsch; E Lotzová; Gabriel N Hortobagyi; Raphael Pollock
Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.
Surgical oncology 1994;3(4):211-9.
1994: Gabriel N Hortobagyi
Multidisciplinary management of advanced primary and metastatic breast cancer.
Cancer 1994;74(1 Suppl):416-23.
1994: Kapil Dhingra; Nour Sneige; Tej K Pandita; D A Johnston; J S Lee; K Emami; Gabriel N Hortobagyi; Walter N Hittelman
Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections.
Cytometry 1994;16(2):100-12.
1994: Aman U Buzdar; S Kau; Gabriel N Hortobagyi; Richard L Theriault; Daniel J Booser; Frankie A Holmes; R Walters; I H Krakoff
Phase I trial of droloxifene in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1994;33(4):313-6.
1994: Aman U Buzdar; Gabriel N Hortobagyi; Debra Frye; D Ho; Daniel J Booser; Vicente Valero; Frankie A Holmes; B K Birmingham; K Bui; C Yeh
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):50-4.
1994: Kapil Dhingra; Vicente Valero; L Gutierrez; Richard L Theriault; Daniel J Booser; Frankie A Holmes; Aman U Buzdar; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of deoxyspergualin in metastatic breast cancer.
Investigational new drugs 1994;12(3):235-41.
1993: O E Nieweg; W H Wong; S Eva Singletary; Gabriel N Hortobagyi; E Edmund Kim
Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy.
Annals of the New York Academy of Sciences 1993;698():423-8.
1993: O E Nieweg; E Edmund Kim; W H Wong; W F Broussard; S Eva Singletary; Gabriel N Hortobagyi; R S Tilbury
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Cancer 1993;71(12):3920-5.
1993: Aman U Buzdar; S W Kau; Terry L Smith; Frederick C Ames; Eva Singletary; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi
The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer.
Cancer 1993;71(11):3680-4.
1993: Gabriel N Hortobagyi
Mitomycin: its evolving role in the treatment of breast cancer.
Oncology 1993;50 Suppl 1():1-8.
1993: Richard L Theriault; Giuseppe Fraschini; Frankie A Holmes; Debra Frye; Jordan U Gutterman; Gabriel N Hortobagyi
The myeloprotective effect of recombinant human granulocyte-macrophage colony-stimulating factor given sequentially with continuous infusion vinblastine in metastatic breast cancer patients.
American journal of clinical oncology 1993;16(2):132-6.
1993: Albert Deisseroth; E G Hanania; S Fu; David F Claxton; Michael Andreeff; Richard Champlin; John Kavanagh; Gabriel N Hortobagyi; Frankie A Holmes; C Reading
Genetic therapy of human neoplastic disease.
Journal of hematotherapy 1993;2(3):373-5.
1992: Gabriel N Hortobagyi
Activity of ifosfamide in breast cancer.
Seminars in oncology 1992;19(6 Suppl 12):36-41.
1992: Narin Voravud; Richard L Theriault; Gabriel N Hortobagyi
Vertebral osteomyelitis mimicking bone metastasis in breast cancer patients.
American journal of clinical oncology 1992;15(5):428-32.
1992: Aman U Buzdar; Gabriel N Hortobagyi; S W Kau; Terry L Smith; Giuseppe Fraschini; Frankie A Holmes; Jordan U Gutterman; V M Hug; S Eva Singletary; Frederick C Ames
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1540-6.
1992: Daniel J Booser; Gabriel N Hortobagyi
Treatment of locally advanced breast cancer.
Seminars in oncology 1992;19(3):278-85.
1992: I A Jaiyesimi; Aman U Buzdar; Gabriel N Hortobagyi
Inflammatory breast cancer: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):1014-24.
1992: S Eva Singletary; Marsha D McNeese; Gabriel N Hortobagyi
Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.
Cancer 1992;69(11):2849-52.
1992: Ronald S Walters; Richard L Theriault; Frankie A Holmes; Gabriel N Hortobagyi; L Esparza
Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.
Investigational new drugs 1992;10(1):43-4.
1992: Ronald S Walters; Debra Frye; Aman U Buzdar; Frankie A Holmes; Gabriel N Hortobagyi
A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.
Cancer 1992;69(2):476-81.
1992: Aman U Buzdar; S W Kau; Gabriel N Hortobagyi; Frederick C Ames; Frankie A Holmes; Giuseppe Fraschini; V Hug; Richard L Theriault; Marsha D McNeese; S Eva Singletary
Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.
Cancer 1992;69(2):448-52.
1992: J R Simmons; Aman U Buzdar; D M Ota; K Marts; Gabriel N Hortobagyi
Complications associated with indwelling catheters.
Medical and pediatric oncology 1992;20(1):22-5.
1992: Kapil Dhingra; Aysegul Sahin; J Supak; S Y Kim; Gabriel N Hortobagyi; Walter N Hittelman
Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.
Breast cancer research and treatment 1992;23(3):201-10.
1992: Gabriel N Hortobagyi
Overview of new treatments for breast cancer.
Breast cancer research and treatment 1992;21(1):3-13.
1991: Frankie A Holmes; Ronald S Walters; Richard L Theriault; A D Forman; L K Newton; Martin N Raber; Aman U Buzdar; Debra Frye; Gabriel N Hortobagyi
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
Journal of the National Cancer Institute 1991;83(24):1797-805.
1991: Giuseppe Fraschini; Frankie A Holmes; L Esparza; Richard L Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Phase I-II study of high-dose etoposide in patients with refractory breast cancer.
Investigational new drugs 1991;9(4):365-7.
1991: SD Huan; JC Yau; Frank Dunphy; R O Wallerstein; K Dicke; V Spencer; Charles F LeMaistre; Albert Deisseroth; Gabriel N Hortobagyi; Frankie A Holmes
Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1609-17.
1991: Gabriel N Hortobagyi
Bone metastases in breast cancer patients.
Seminars in oncology 1991;18(4 Suppl 5):11-5.
1991: J E Macheledt; Aman U Buzdar; Gabriel N Hortobagyi; Debra Frye; J U Gutterman; Frankie A Holmes
Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.
Breast cancer research and treatment 1991;18(3):165-70.
1991: L D Ziegler; J H Connelly; Debra Frye; Terry L Smith; Gabriel N Hortobagyi
Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer.
Cancer 1991;68(3):628-33.
1991: A A Sahin; Jae Y Ro; J Y Ro; M B Blick; Adel K El-Naggar; Nelson G Ordonez; H A Fritsche; Terry L Smith; Gabriel N Hortobagyi; Alberto G Ayala
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
Cancer 1991;68(3):549-57.
1991: Giuseppe Fraschini; A Ciociola; L Esparza; D Templeton; Frankie A Holmes; Ronald S Walters; Gabriel N Hortobagyi
Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1268-74.
1991: Sen Pathak; Vicki L Hopwood; Gabriel N Hortobagyi; G L Jackson; J I Hughes; D Melillo
Chromosome anomalies in human breast cancer: evidence for specific involvement of 1q region in lymphocyte cultures.
Anticancer research 1991;11(3):1055-60.
1991: V Hug; S Kau; Gabriel N Hortobagyi; Lovell Jones
Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone.
British journal of cancer 1991;63(3):454-6.
1991: J R Broadwater; M J Edwards; C Kuglen; Gabriel N Hortobagyi; Frederick C Ames; Charles M Balch
Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity.
Annals of surgery 1991;213(2):126-9.
1990: R Wallerstein; G Spitzer; Frank Dunphy; SD Huan; Gabriel N Hortobagyi; JC Yau; Aman U Buzdar; Frankie A Holmes; Richard L Theriault; Michael S Ewer
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1782-8.
1990: Gabriel N Hortobagyi
Comprehensive management of locally advanced breast cancer.
Cancer 1990;66(6 Suppl):1387-91.
1990: Jae Y Ro; Aysegul Sahin; J Y Ro; H Fritsche; Gabriel N Hortobagyi; M Blick
Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Human pathology 1990;21(8):787-91.
1990: Frank Dunphy; G Spitzer; Aman U Buzdar; Gabriel N Hortobagyi; L J Horwitz; JC Yau; J A Spinolo; Sundar Jagannath; Frankie A Holmes; R O Wallerstein
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1207-16.
1990: Frankie A Holmes; Herbert A Fritsche; J W Loewy; A M Geitner; R C Sutton; Aman U Buzdar; Gabriel N Hortobagyi
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1025-35.
1990: Ruth Katz; S Patel; Nour Sneige; H A Fritsche; Gabriel N Hortobagyi; F C Ames; T Brooks; N G Ordonez
Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.
Breast cancer research and treatment 1990;15(3):191-203.
1990: R Sutton; Aman U Buzdar; Gabriel N Hortobagyi
Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.
Cancer 1990;65(4):847-50.
1990: Aman U Buzdar; Marsha D McNeese; Gabriel N Hortobagyi; Terry L Smith; S Kau; Giuseppe Fraschini; V Hug; N Ellerbroek; Frankie A Holmes; Frederick C Ames
Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?
Cancer 1990;65(3):394-9.
1990: Aman U Buzdar; Gabriel N Hortobagyi; L T Esparza; Frankie A Holmes; J S Ro; Giuseppe Fraschini; B Lichtiger
Elliptinium acetate in metastatic breast cancer--a phase II study.
Oncology 1990;47(2):101-4.
1990: Gabriel N Hortobagyi; Richard L Theriault; Debra Frye; Ronald S Walters; Giuseppe Fraschini; C K Tashima; J S Ro; E Salewski; Aman U Buzdar
Pirarubicin in combination chemotherapy for metastatic breast cancer.
American journal of clinical oncology 1990;13 Suppl 1():S54-6.
1990: N Vanek; Gabriel N Hortobagyi; Aman U Buzdar
Radiotherapy enhances the toxicity of aminoglutethimide.
Medical and pediatric oncology 1990;18(2):162-4.
1989: J S Ro; Adel El-Naggar; Jae Y Ro; M Blick; Debra Frye; Giuseppe Fraschini; H Fritsche; Gabriel N Hortobagyi
c-erbB-2 amplification in node-negative human breast cancer.
Cancer research 1989;49(24 Pt 1):6941-4.
1989: S S Givens; N A Ellerbroek; J J Butler; HI Libshitz; Gabriel N Hortobagyi; Marsha D McNeese
Angiosarcoma arising in an irradiated breast. A case report and review of the literature.
Cancer 1989;64(11):2214-6.
1989: P T Ang; Aman U Buzdar; Terry L Smith; S Kau; Gabriel N Hortobagyi
Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1677-84.
1989: E H Koh; Jae Y Ro; David M Wildrick; Gabriel N Hortobagyi; M Blick
Analysis of the estrogen receptor gene structure in human breast cancer.
Anticancer research 1989;9(6):1841-5.
1989: H Z Patel; Aman U Buzdar; Gabriel N Hortobagyi
Role of adjuvant chemotherapy in male breast cancer.
Cancer 1989;64(8):1583-5.
1989: Gabriel N Hortobagyi; V Hug; Aman U Buzdar; S W Kau; Frankie A Holmes; H A Fritsche
Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Cancer 1989;64(5):1002-6.
1989: K Jabboury; Frankie A Holmes; Gabriel N Hortobagyi
5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer.
Cancer 1989;64(4):793-7.
1989: K Jabboury; Debra Frye; Frankie A Holmes; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Investigational new drugs 1989;7(2-3):225-9.
1989: M Taha; N G Ordoñez; S Kulkarni; M Owen; J S Ro; Gabriel N Hortobagyi; C L Reading; K A Dicke; G Spitzer
A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
Bone marrow transplantation 1989;4(3):297-303.
1989: Aman U Buzdar; S W Kau; Terry L Smith; Gabriel N Hortobagyi
Ten-year results of FAC adjuvant chemotherapy trial in breast cancer.
American journal of clinical oncology 1989;12(2):123-8.
1989: Richard L Theriault; Gabriel N Hortobagyi; H A Fritsche; Debra Frye; R Martinez; Aman U Buzdar
The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.
Cancer 1989;63(5):828-35.
1989: P S Chu; Aman U Buzdar; Gabriel N Hortobagyi
Trilostane with hydrocortisone in treatment of metastatic breast cancer.
Breast cancer research and treatment 1989;13(2):117-21.
1989: J Ro; J Bresser; Jae Y Ro; F Brasfield; Gabriel N Hortobagyi; M Blick
SIS/PDGF-B expression in benign and malignant human breast lesions.
Oncogene 1989;4(3):351-4.
1989: Gabriel N Hortobagyi; H Y Yap; S W Kau; Giuseppe Fraschini; Michael S Ewer; S P Chawla; Robert S Benjamin
A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer.
American journal of clinical oncology 1989;12(1):57-62.
1989: Gabriel N Hortobagyi; Debra Frye; Aman U Buzdar; Michael S Ewer; Giuseppe Fraschini; V Hug; Frederick C Ames; E Montague; C H Carrasco; Bruce Mackay
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.
Cancer 1989;63(1):37-45.
1989: Nour Sneige; V A White; Ruth Katz; P Troncoso; H I Libshitz; Gabriel N Hortobagyi
Ductal carcinoma-in-situ of the breast: fine-needle aspiration cytology of 12 cases.
Diagnostic cytopathology 1989;5(4):371-7.
1988: Gabriel N Hortobagyi; Frederick C Ames; Aman U Buzdar; S W Kau; Marsha D McNeese; D Paulus; V Hug; Frankie A Holmes; MM Romsdahl; Giuseppe Fraschini
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Cancer 1988;62(12):2507-16.
1988: Richard L Theriault; Gabriel N Hortobagyi; S W Kau; Frankie A Holmes; V Hug; Giuseppe Fraschini; K Jabboury; Aman U Buzdar
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Cancer 1988;62(10):2105-10.
1988: Aman U Buzdar; Gabriel N Hortobagyi; Terry L Smith; S Kau; C Marcus; Frankie A Holmes; V Hug; Giuseppe Fraschini; Frederick C Ames; R G Martin
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Cancer 1988;62(10):2098-104.
1988: Gabriel N Hortobagyi
The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer.
Bone marrow transplantation 1988;3(6):525-30.
1988: Gabriel N Hortobagyi; Aman U Buzdar
Management of locally advanced breast cancer.
American journal of clinical oncology 1988;11(5):597-601.
1988: Giuseppe Fraschini; Frankie A Holmes; Aman U Buzdar; V Hug; Gabriel N Hortobagyi
Cisplatin in combination with continuous infusion vinblastine for refractory breast cancer.
American journal of clinical oncology 1988;11(4):448-50.
1988: E Berté; Aman U Buzdar; Terry L Smith; Gabriel N Hortobagyi
Bilateral primary breast cancer in patients treated with adjuvant therapy.
American journal of clinical oncology 1988;11(2):114-8.
1988: Giuseppe Fraschini; Chusilp Charnsangavej; C H Carrasco; Aman U Buzdar; K W Jabboury; Gabriel N Hortobagyi
Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver.
American journal of clinical oncology 1988;11(1):34-8.
1988: Aman U Buzdar; C Marcus; Frankie A Holmes; V Hug; Gabriel N Hortobagyi
Phase II evaluation of Ly156758 in metastatic breast cancer.
Oncology 1988;45(5):344-5.
1988: Jae Y Ro; S M North; Gary E Gallick; Gabriel N Hortobagyi; Jordan U Gutterman; M Blick
Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.
Cancer research 1988;48(1):161-4.
1987: Gabriel N Hortobagyi; Debra Frye; Frankie A Holmes; V Hug; Giuseppe Fraschini; A U Buzdar
Phase II study of iproplatin in metastatic breast carcinoma.
Cancer treatment reports 1987;71(12):1193-6.
1987: Gabriel N Hortobagyi; Aman U Buzdar; Debra Frye; V Hug; Giuseppe Fraschini; Frederick C Ames; E Montague; Jordan U Gutterman; R G Martin
Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial.
Cancer 1987;60(11):2596-604.
1987: Giuseppe Fraschini; G Fleishman; Chusilp Charnsangavej; C H Carrasco; Gabriel N Hortobagyi
Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer.
Cancer treatment reports 1987;71(11):1001-5.
1987: Giuseppe Fraschini; G Fleishman; H Y Yap; C H Carrasco; Chusilp Charnsangavej; Y Z Patt; Gabriel N Hortobagyi
Percutaneous hepatic arterial infusion of cisplatin for metastatic breast cancer.
Cancer treatment reports 1987;71(3):313-5.